<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7570746</article-id><article-id pub-id-type="doi">10.3390/molecules25184102</article-id><article-id pub-id-type="publisher-id">molecules-25-04102</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9740-3989</contrib-id><name><surname>Muniyandi</surname><given-names>Kasipandi</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04102">1</xref><xref ref-type="aff" rid="af2-molecules-25-04102">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0700-9246</contrib-id><name><surname>George</surname><given-names>Blassan</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04102">1</xref></contrib><contrib contrib-type="author"><name><surname>Parimelazhagan</surname><given-names>Thangaraj</given-names></name><xref ref-type="aff" rid="af2-molecules-25-04102">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5002-827X</contrib-id><name><surname>Abrahamse</surname><given-names>Heidi</given-names></name><xref ref-type="aff" rid="af1-molecules-25-04102">1</xref><xref rid="c1-molecules-25-04102" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Lupi&#x000e1;&#x000f1;ez</surname><given-names>Jos&#x000e9; Antonio</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-04102"><label>1</label>Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, 17011, Doornfontein 2028, South Africa; <email>kasim@uj.ac.za</email> (K.M.); <email>blassang@uj.ac.za</email> (B.G.)</aff><aff id="af2-molecules-25-04102"><label>2</label>Bioprospecting Laboratory, Department of Botany, School of Life Sciences, Bharathiar University, Coimbatore, Tamil Nadu 641046, India; <email>drparimel@buc.edu.in</email></aff><author-notes><corresp id="c1-molecules-25-04102"><label>*</label>Correspondence: <email>habrahamse@uj.ac.za</email></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2020</year></pub-date><volume>25</volume><issue>18</issue><elocation-id>4102</elocation-id><history><date date-type="received"><day>30</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cancer is one of the greatest life-threatening diseases conventionally treated using chemo- and radio-therapy. Photodynamic therapy (PDT) is a promising approach to eradicate different types of cancers. PDT requires the administration of photosensitisers (PSs) and photoactivation using a specific wavelength of light in the presence of molecular oxygen. This photoactivation exerts an anticancer effect via apoptosis, necrosis, and autophagy of cancer cells. Recently, various natural compounds that exhibit photosensitising potentials have been identified. Photoactive substances derived from medicinal plants have been found to be safe in comparison with synthetic compounds. Many articles have focused on PDT mechanisms and types of PSs, but limited attention has been paid to the phototoxic activities of phytocompounds. The reduced toxicity and side effects of natural compounds inspire the researchers to identify and use plant extracts or phytocompounds as a potent natural PS candidate for PDT. This review focusses on the importance of common photoactive groups (furanocoumarins, polyacetylenes, thiophenes, curcumins, alkaloids, and anthraquinones), their phototoxic effects, anticancer activity and use as a potent PS for an effective PDT outcome in the treatment of various cancers.</p></abstract><kwd-group><kwd>photodynamic therapy</kwd><kwd>cancer</kwd><kwd>photosensitiser</kwd><kwd>natural compounds</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-04102"><title>1. Introduction</title><p>Cancer is one of the deadliest diseases reported in developed as well as developing countries [<xref rid="B1-molecules-25-04102" ref-type="bibr">1</xref>]. It is mainly characterised by the uncontrolled cell growth and development of normal cells due to genetic alterations or exposure to the carcinogenic substances. The mutation of normal cells leads to abnormal cellular proliferation and develops into tumour [<xref rid="B2-molecules-25-04102" ref-type="bibr">2</xref>]; this can be either benign, premalignant (non-cancerous) or malignant (cancerous) [<xref rid="B3-molecules-25-04102" ref-type="bibr">3</xref>,<xref rid="B4-molecules-25-04102" ref-type="bibr">4</xref>]. Presently surgery, radiotherapy, and chemotherapy either as monotherapy or as combined treatments are used in the treatment of cancer. However, these treatments frequently stimulate redundant side effects [<xref rid="B2-molecules-25-04102" ref-type="bibr">2</xref>]. Many of the current chemotherapeutic drugs are of low molecular weight with high pharmacokinetic profiles [<xref rid="B4-molecules-25-04102" ref-type="bibr">4</xref>]. Hence, in order to achieve the bioavailability and cytotoxicity induction, the drugs are administrated in high concentrations. In photodynamic therapy (PDT), photoactive drugs are generally administered systemically, but because of the precise application of light from the laser source, the cytotoxicity is attained in the tumour location. Due to the lesser drug specificity and toxicity to healthy cells, the chemotherapeutic drugs used in cancer treatments need to be improved.</p><p>Photodynamic therapy (PDT) is a promising minimally invasive therapy for the treatment of cancer. This involves the administration of photosensitiser (PS) and subsequent excitation of PS by light irradiation at a specific wavelength. The excited PS then reacts with cellular oxygen and produces reactive oxygen species (ROS). This reaction results in oxidising the cellular macromolecules surrounding tumour cells [<xref rid="B5-molecules-25-04102" ref-type="bibr">5</xref>]. This remedial method has been developed over the last few years [<xref rid="B6-molecules-25-04102" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-04102" ref-type="bibr">7</xref>], and has not only been utilised in cancer treatment, but also in dermatological [<xref rid="B8-molecules-25-04102" ref-type="bibr">8</xref>] and ophthalmic [<xref rid="B9-molecules-25-04102" ref-type="bibr">9</xref>] conditions, including psoriasis and age-related diseases [<xref rid="B10-molecules-25-04102" ref-type="bibr">10</xref>,<xref rid="B11-molecules-25-04102" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-04102" ref-type="bibr">12</xref>]. The use of photodynamic therapy to treat cancers has gained attention around the world [<xref rid="B13-molecules-25-04102" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-04102" ref-type="bibr">14</xref>]. The mechanism of PDT is based on various photocatalytic reactions that induce the destruction of cancer cells, and it has been clinically used for the treatment of cancer for over a decade [<xref rid="B5-molecules-25-04102" ref-type="bibr">5</xref>]. In the first clinical PDT study reported by Granelli et al. [<xref rid="B15-molecules-25-04102" ref-type="bibr">15</xref>], hematoporphyrin was used as a potent photosensitiser (PS) against glioma cancer cells. PDT destroys cancer cells through three fundamentally different pathways, namely, by damaging cancer cells over time, damaging vascular tissues that supply oxygen to cells, and finally by activating host immune response systems [<xref rid="B13-molecules-25-04102" ref-type="bibr">13</xref>,<xref rid="B16-molecules-25-04102" ref-type="bibr">16</xref>]. Combining PDT with chemotherapy, radiotherapy, and herbal therapy could be an emerging future methodology in cancer treatment. The combination therapy has more of a tendency to reduce the side effects when compared to monotherapy regimes and can significantly lower cancer cell proliferation by improving the drug uptake [<xref rid="B17-molecules-25-04102" ref-type="bibr">17</xref>].</p><p>Since ancient times, herbal medicine from natural products has been utilised for treating various human ailments [<xref rid="B18-molecules-25-04102" ref-type="bibr">18</xref>]. Most current medicines are derived from various medicinal plants, and it is evident that herbal extracts and their compounds should be examined as possible active lead components in cancer drug discoveries [<xref rid="B19-molecules-25-04102" ref-type="bibr">19</xref>,<xref rid="B20-molecules-25-04102" ref-type="bibr">20</xref>]. Nature is a valuable reserve for medicinal plants, and many of the pharmaceutically active compounds isolated from medicinal plants have not been tested for photoactive properties. There have been few studies attempting to identify new chemical compounds with photoactivity from plant extracts that can be used as potent natural PSs [<xref rid="B21-molecules-25-04102" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-04102" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-04102" ref-type="bibr">23</xref>,<xref rid="B24-molecules-25-04102" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-04102" ref-type="bibr">25</xref>]. Hypericin (isolated from <italic>Hypericum perforatum</italic>) is a recognised plant-based PS used in PDT. The in vitro and in vivo studies reported that hypericin PS activated at 594 nm could destroy cancer cell proliferation effectively. The researchers already demonstrated that the effect of herbal extracts combined with illumination could significantly reduce cancer development by prohibiting metabolic viability and proliferation cancer cells [<xref rid="B26-molecules-25-04102" ref-type="bibr">26</xref>,<xref rid="B27-molecules-25-04102" ref-type="bibr">27</xref>,<xref rid="B28-molecules-25-04102" ref-type="bibr">28</xref>,<xref rid="B29-molecules-25-04102" ref-type="bibr">29</xref>].</p><p>Due to the low or no adverse side effects, herbal products have been used for the treatment of many more ailments than synthetic drugs. Studies have shown that plant-based compounds could be used in the treatment of various cancers [<xref rid="B30-molecules-25-04102" ref-type="bibr">30</xref>]. Many phototoxic substances were subsequently reported in various plant species that are equally efficient as of conventional PSs [<xref rid="B31-molecules-25-04102" ref-type="bibr">31</xref>]. These studies recommend that natural compounds with photosensitising abilities can be isolated from plants and used as alternatives for conventional PSs used in PDT. In this review, the underlying principles of PDT, PSs and plant-based photoactive compounds were addressed. This review mainly focused on the anticancer activity of furanocoumarins, polyacetylenes, thiophenes, curcumins, alkaloids and anthraquinones in relation to the light-absorbing properties.</p></sec><sec id="sec2-molecules-25-04102"><title>2. Basic Principles of Photodynamic Therapy</title><p>Photodynamic therapy involves coordination with three individual factors, namely, the photosensitiser, oxygen, and light [<xref rid="B7-molecules-25-04102" ref-type="bibr">7</xref>]. These components are not toxic to cells individually, but when irradiated, these can initiate a photochemical reaction that generates highly reactive singlet oxygen (<sup>1</sup>O<sub>2</sub>) and cause significant toxicity, leading to cell death. PDT is normally described in two stages, the first is administration of the PS and the second stage is the irradiation. Generally, the effect of PDT is affected by the PS type, dosage, light fluence, as well as exposure time. PDT can be used either before or after chemotherapy, radiotherapy, or surgery without compromise. The clinically approved PS should not accumulate in the body and does not develop resistant cancer cells. Pain during administration and continuous photosensitisation are the major drawbacks of PDT treatment. There are three types of lights ranges from 600 to 800 nm that are commonly used in PDT, namely, blue, red, and infrared lights. Among them, blue light penetrates the tissue the least when compared to red and infrared lights. The wavelengths below 800 nm are mostly used in PDT than higher wavelengths (above 800 nm) due to their lack of photodynamic reactions. The choice of light source is commonly based on PS nature, absorption spectra of PS, location, and size and characteristics of the infected tissue [<xref rid="B7-molecules-25-04102" ref-type="bibr">7</xref>,<xref rid="B32-molecules-25-04102" ref-type="bibr">32</xref>].</p><p>More than 300 chemical compounds have already been identified as potential candidates to be used as PSs. Amongst these, a few were authorised for clinical application in PDT, and others were medically evaluated, whereas some are still under examination [<xref rid="B33-molecules-25-04102" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-04102" ref-type="bibr">34</xref>]. We have tabulated some PSs which are used in various cancer treatments in <xref rid="molecules-25-04102-t001" ref-type="table">Table 1</xref>. Photosensitisers are naturally or chemically produced compound conjugated with a visible light-absorbing chromophore group with a strong chemical absorbance. Choosing the correct PS is the most important phase in PDT for a successful outcome [<xref rid="B33-molecules-25-04102" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-04102" ref-type="bibr">34</xref>]. The purity and the presence of a tetrapyrrole structure with good storage stability are the preferable properties of most PSs used in PDT. The potent and effective PS should have the ability to initiate a photodynamic reaction after irradiation with 600&#x02013;800 nm lights and should not cause any toxicity under dark conditions. It should be easily distinguishable from the body with no or minimum phototoxic side effects [<xref rid="B35-molecules-25-04102" ref-type="bibr">35</xref>]. The better diffusion of PS through the cells after long administration might contribute to the effectiveness of PDT [<xref rid="B36-molecules-25-04102" ref-type="bibr">36</xref>]. The production of a significant amount of ROS after irradiation that induces apoptosis with less inflammation is most likely to be a suitable PS for PDT application [<xref rid="B37-molecules-25-04102" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-04102" ref-type="bibr">38</xref>]. </p><p>When a PS is subjected to a particular wavelength light, the electron of the outermost orbital will be shifted from the ground state (S0) to the first excited state (S1). Subsequently, the electromagnetic propulsion switches the molecule to an excited triplet state (T1) with a longer life span (<xref ref-type="fig" rid="molecules-25-04102-f001">Figure 1</xref>). In each of these excited states, PSs are quite unstable and lose their energy in the form of fluorescence, phosphorescence, and internal heat conversion. PSs in the T1 state may react photochemically in any of the two pathways. In the type 1 pathway, the excited PS reacts through an electron transfer process with the surrounding oxygen, which ultimately leads to generation of reactive oxygen species (ROS). Such free radicals communicate readily with the biomolecules (lipids, peptides, proteins, and nucleic acids) and destroy them [<xref rid="B39-molecules-25-04102" ref-type="bibr">39</xref>,<xref rid="B40-molecules-25-04102" ref-type="bibr">40</xref>]. In contrast, in the type 2 pathway, the energy is directly transferred from the T1 state of the PS to the S0-state oxygen. This results in the ground-state PS transformation and excited-state singlet reactive oxygen. The disruption caused by PDT is local because both singlet oxygen as well as free radicals have a short half-life between 10&#x02013;300 nanoseconds and a small diffusion distance of 10&#x02013;55 nm [<xref rid="B41-molecules-25-04102" ref-type="bibr">41</xref>].</p><table-wrap id="molecules-25-04102-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04102-t001_Table 1</object-id><label>Table 1</label><caption><p>List of photosensitisers used in photodynamic therapy of various cancers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Photosensitiser</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Commercial Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x003bb; max (nm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Cancer</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>First-Generation Photosensitiser</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hematoporphyrin derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Photofrin Photoheme</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">630</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lung, bladder, skin, cervical, breast cancer.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-25-04102" ref-type="bibr">17</xref>,<xref rid="B42-molecules-25-04102" ref-type="bibr">42</xref>]</td></tr><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<bold>Second-Generation Photosensitisers</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-Aminolevulinic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Levulan<break/>Alasens</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">635</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bladder, skin, lung, ovary and gastrointestinal cancer.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B43-molecules-25-04102" ref-type="bibr">43</xref>,<xref rid="B44-molecules-25-04102" ref-type="bibr">44</xref>,<xref rid="B45-molecules-25-04102" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meta-tetra(hydroxyphenyl) chlorin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Foscan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">652</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Approved drug for the treatment of bronchial and oesophageal cancers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B46-molecules-25-04102" ref-type="bibr">46</xref>,<xref rid="B47-molecules-25-04102" ref-type="bibr">47</xref>,<xref rid="B48-molecules-25-04102" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chlorin e6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MACEDACEPhotoditazine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">664</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i004.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gynaecological diseases, prostate cancer, fibrosarcoma, Liver, brain, lung, and oral cancers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-molecules-25-04102" ref-type="bibr">49</xref>,<xref rid="B50-molecules-25-04102" ref-type="bibr">50</xref>,<xref rid="B51-molecules-25-04102" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Benzoporphyrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Visudyne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">690</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i005.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prostate and skin cancer.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-molecules-25-04102" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-04102" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Texaphyrins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lutrin, Antrin,<break/>Optrin, Xcytrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">720&#x02013;760</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i006.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocellular cancer, leukaemia, nasopharyngeal carcinoma, colon, prostate, bronchial and oesophageal cancers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-molecules-25-04102" ref-type="bibr">54</xref>,<xref rid="B55-molecules-25-04102" ref-type="bibr">55</xref>,<xref rid="B56-molecules-25-04102" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-04102" ref-type="bibr">57</xref>,<xref rid="B58-molecules-25-04102" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phthalocyanines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Photosense</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">640&#x02013;690 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i007.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast, cervical, skin, lung, liver, colon and gastrointestinal cancers.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-molecules-25-04102" ref-type="bibr">17</xref>,<xref rid="B59-molecules-25-04102" ref-type="bibr">59</xref>,<xref rid="B60-molecules-25-04102" ref-type="bibr">60</xref>,<xref rid="B61-molecules-25-04102" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Purpurins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Purlytin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">660</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04102-i008.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast cancer, prostate cancer and Kaposi&#x02019;s sarcoma.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-molecules-25-04102" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-04102" ref-type="bibr">63</xref>,<xref rid="B64-molecules-25-04102" ref-type="bibr">64</xref>]</td></tr></tbody></table></table-wrap></sec><sec id="sec3-molecules-25-04102"><title>3. PDT&#x02019;s Cancer Cell Death Mechanism</title><p>PDT&#x02019;s cancer cell death mechanism starts after the activation of administrated PS by a specific wavelength of light. The PS&#x02019;s hydrophilic, hydrophobic, and ionic charge-related interaction nature plays an important role in the targeting of particular cancer cell receptor (globulins and Low-Density Lipoprotein (LDL) receptors) [<xref rid="B34-molecules-25-04102" ref-type="bibr">34</xref>]. After the activation of PSs, the cancer cell death mechanism might occur in three main pathways (<xref ref-type="fig" rid="molecules-25-04102-f001">Figure 1</xref>), namely, apoptosis, necrosis, and autophagy [<xref rid="B33-molecules-25-04102" ref-type="bibr">33</xref>,<xref rid="B65-molecules-25-04102" ref-type="bibr">65</xref>,<xref rid="B66-molecules-25-04102" ref-type="bibr">66</xref>]. However, the level of cell death induced by PDT may be affected by various aspects, including subcellular localisation, bioavailability, the physicochemical nature of the PS, the cellular oxygen concentration, as well as the applied light intensity and wavelength [<xref rid="B67-molecules-25-04102" ref-type="bibr">67</xref>]. In general, the light-absorbed PS interacts with cellular oxygen and highly produce ROS (hydroperoxides, superoxide, or hydroxyl radicals) as well as singlet oxygen (<sup>1</sup>O<sub>2</sub>). These produced ROS can induce cancerous cell death via the above-mentioned mechanisms. Both type 1 and 2 reactions may occur separately or in combination, but type 1 (generation of ROS followed by the apoptotic cell death mechanism) is commonly exhibited by most approved PSs [<xref rid="B67-molecules-25-04102" ref-type="bibr">67</xref>].</p></sec><sec id="sec4-molecules-25-04102"><title>4. PS from Natural Resources</title><p>The effectiveness of PDT is mainly based on the PS; it should possess all the properties of the PS as previously explained. The PS can be divided into first- and second-generation types. Hematoporphyrin and its derivative Photofrin<sup>&#x000ae;&#x000ae;</sup> were classified as first-generation PSs. After extensive studies, new and improved second-generation PSs, such as Levulan<sup>&#x000ae;&#x000ae;</sup>, Alasens<sup>&#x000ae;&#x000ae;</sup>, and Foscan have been introduced for PDT application (<xref rid="molecules-25-04102-t001" ref-type="table">Table 1</xref>). Although these are widely used for various cancer treatments, their clinical usage is limited by various drawbacks such as lack of chemical purity, a longer half-life, accumulation in tissues and poor ability in relation to depth of tissue penetration [<xref rid="B31-molecules-25-04102" ref-type="bibr">31</xref>,<xref rid="B32-molecules-25-04102" ref-type="bibr">32</xref>,<xref rid="B33-molecules-25-04102" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-04102" ref-type="bibr">34</xref>,<xref rid="B35-molecules-25-04102" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-04102" ref-type="bibr">36</xref>,<xref rid="B37-molecules-25-04102" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-04102" ref-type="bibr">38</xref>,<xref rid="B39-molecules-25-04102" ref-type="bibr">39</xref>].</p><p>Subsequently, there are some research reports on PSs with potent pharmaceutical properties to overcome the shortcomings of first- (Porphyrin based sensitisers) and second-generation (non-porphyrin derivatives) PSs [<xref rid="B35-molecules-25-04102" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-04102" ref-type="bibr">36</xref>,<xref rid="B37-molecules-25-04102" ref-type="bibr">37</xref>]. These drawbacks of current PSs specifically imply the need for new PSs as anticancer agents from natural resources. The discovery of new PS compounds with anticipated pharmacological properties and clinical application is an inspiring task. Recently, a greater number of plant-based compounds have been reported for their anticancer activity, and these compounds are pharmaceutically very important for the development of potent drugs. The use of light to activate the bioactivities of natural products is generally called photopharmacology (a combination of photophysics and photochemistry). The absorption of lights (&#x003bb; &#x0003c; 350 nm) by a molecule mainly depends on the chromophore compound attached (<xref ref-type="fig" rid="molecules-25-04102-f002">Figure 2</xref>) [<xref rid="B36-molecules-25-04102" ref-type="bibr">36</xref>,<xref rid="B37-molecules-25-04102" ref-type="bibr">37</xref>]. This review presents an overview of natural photoactive compounds as potent third-generation photosensitisers in the improvement of PSs in relation to their prospective application in cancer treatments.</p></sec><sec id="sec5-molecules-25-04102"><title>5. Natural Photoactive Compounds from Plants</title><p>The search for the natural compounds as efficient PSs has been progressively moving forward because of the side effects caused by current synthetic drugs. The advanced isolation, identification and characterisation techniques improved the extraction of desirable compounds from plants. Recently, using these advanced techniques, the isolation of natural photoactive compounds has become easy. Although there have been few studies attempting to identify new chemical compounds with photoactivity from plant extracts, this review discusses the photoactivity as well as the anticancer activity of some plant-based compounds such as furanocoumarins, polyacetylenes, thiophenes, curcumins, alkaloids and anthraquinones (<xref rid="molecules-25-04102-t002" ref-type="table">Table 2</xref>).</p><sec id="sec5dot1-molecules-25-04102"><title>5.1. Furanocoumarins</title><p>The secondary metabolites, furanocoumarins (FC; <xref ref-type="fig" rid="molecules-25-04102-f003">Figure 3</xref>), are mostly present in higher plants. The photoactive furanocoumarins were mainly composed of a linear core, and the biological distribution, photochemistry and phototoxicity mechanisms of FC after PUVA (psoralen and long-wave ultraviolet radiation) irradiation were reported in previous study [<xref rid="B92-molecules-25-04102" ref-type="bibr">92</xref>]. In terms of phototherapy, psoralen is activated in the wavelength range of 300&#x02013;400 nm ultraviolet radiation to treat psoriasis, dermatitis, eczema, and other skin problems [<xref rid="B92-molecules-25-04102" ref-type="bibr">92</xref>]. Over a few years, many researchers reported anticancer activity of FCs against various types of cancer such as breast, skin, and leukaemia. FCs modulate several pathways inducing cancer cell death by inhibiting signal transducer and activator of transcription 3 (STAT3), nuclear factor-&#x003ba;B (NF-&#x003ba;B), phosphatidylinositol-3-kinase and AKT protein expression (<xref ref-type="fig" rid="molecules-25-04102-f004">Figure 4</xref>). These pathways play a key role in tumour development through regular activation of several inflammatory genes. Studies show that FC displayed potent activity against breast cancer development by inhibiting STAT3 protein expression [<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>]. Panno et al. [<xref rid="B92-molecules-25-04102" ref-type="bibr">92</xref>,<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>], demonstrated inhibition of breast cancer cell growth in a dose-dependent manner through activation of p53 and Bax, leading to the cleavage of caspase 9. In contrast, in leukaemia cells, FC inactivated the JAK (Janus-activated kinase), protein c-Src, and STAT3, and downregulated Bcl-xl and Bcl-2 proteins which are responsible for apoptosis [<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04102" ref-type="bibr">94</xref>,<xref rid="B95-molecules-25-04102" ref-type="bibr">95</xref>,<xref rid="B96-molecules-25-04102" ref-type="bibr">96</xref>]. The enhanced activity against the malignant melanoma cell line (A375) after UV irradiation of plant extracts containing FC also supported the possible photoactive nature of FCs [<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04102" ref-type="bibr">94</xref>,<xref rid="B95-molecules-25-04102" ref-type="bibr">95</xref>,<xref rid="B96-molecules-25-04102" ref-type="bibr">96</xref>]. The linear forms of furanocoumarins like psoralen and its derivatives 5-methoxypsoralen (5-MOP) and 8-methoxypsoralen (8-MOP) are reported to increase the cytotoxicity after irradiation by ultraviolet light in the 320&#x02013;400 nm wavelength range against cutaneous T-cell lymphoma [<xref rid="B97-molecules-25-04102" ref-type="bibr">97</xref>,<xref rid="B98-molecules-25-04102" ref-type="bibr">98</xref>], and photoactivated psoralens induce apoptosis by forming adducts with DNA. This leads to the activation of p21waf/Cip and p53 and subsequently leads to cell death by the release of mitochondrial cytochrome c. The photoactivation of psoralen can also cause cell death by blocking oncogenic receptor tyrosine kinase signalling and the PI3K pathway by interfering with efficient recruitment of effector Akt kinase to the activated plasma membrane [<xref rid="B92-molecules-25-04102" ref-type="bibr">92</xref>,<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04102" ref-type="bibr">94</xref>,<xref rid="B95-molecules-25-04102" ref-type="bibr">95</xref>,<xref rid="B96-molecules-25-04102" ref-type="bibr">96</xref>,<xref rid="B97-molecules-25-04102" ref-type="bibr">97</xref>,<xref rid="B98-molecules-25-04102" ref-type="bibr">98</xref>,<xref rid="B99-molecules-25-04102" ref-type="bibr">99</xref>,<xref rid="B100-molecules-25-04102" ref-type="bibr">100</xref>,<xref rid="B101-molecules-25-04102" ref-type="bibr">101</xref>,<xref rid="B102-molecules-25-04102" ref-type="bibr">102</xref>,<xref rid="B103-molecules-25-04102" ref-type="bibr">103</xref>,<xref rid="B104-molecules-25-04102" ref-type="bibr">104</xref>]. PUVA treatment was found effectively against B16F10 murine melanoma cells by cell cycle arrest in G2/M phases [<xref rid="B93-molecules-25-04102" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-04102" ref-type="bibr">94</xref>,<xref rid="B95-molecules-25-04102" ref-type="bibr">95</xref>,<xref rid="B96-molecules-25-04102" ref-type="bibr">96</xref>].</p></sec><sec id="sec5dot2-molecules-25-04102"><title>5.2. Polyacetylene and Thiophenes</title><p>These group compounds are characterised by a triple bond carbon&#x02013;carbon molecule [<xref rid="B75-molecules-25-04102" ref-type="bibr">75</xref>] and thiophenes compounds. Generally, the aliphatic compounds conjugated with three or more acetylenic bonds are considered phototoxic in nature. Among these, polyacetylenes compounds can produce <sup>1</sup>O<sub>2</sub> under irradiation and thiophenes can provide high photo yield, leading to type 2 PDT reaction yields [<xref rid="B105-molecules-25-04102" ref-type="bibr">105</xref>]. The polyacetylene and thiophenes compounds were reported to be activated or excited at a wavelength range of 314&#x02013;350 nm absorbance maximum for the relevant photobiological effects [<xref rid="B75-molecules-25-04102" ref-type="bibr">75</xref>]. The derivatives of these compounds were reported with a variety of potent biological activities, including analgesic, anti-inflammatory, antitumour, and antimicrobial activities. Some of the derivatives substituted by pyrimidines show antimicrobial, anti-inflammatory, and antitumour activities. A few numbers of thiophenes were reported for their cytotoxic effects against human cancer cell lines. <italic>Echinops grijisii</italic> root-derived thiophenes exhibited cytotoxicity against HL-60, K562 and MCF-7 cells [<xref rid="B106-molecules-25-04102" ref-type="bibr">106</xref>]. Notably, derivatives such as thioxopyrimidine and thiazolopyrimidine were reported to possess anticancer activities against MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 (CNS cancer) cells. These acetylenic compounds and derivatives when combined with PDT might improve the efficacy of various cancer treatments [<xref rid="B107-molecules-25-04102" ref-type="bibr">107</xref>,<xref rid="B108-molecules-25-04102" ref-type="bibr">108</xref>,<xref rid="B109-molecules-25-04102" ref-type="bibr">109</xref>,<xref rid="B110-molecules-25-04102" ref-type="bibr">110</xref>,<xref rid="B111-molecules-25-04102" ref-type="bibr">111</xref>,<xref rid="B112-molecules-25-04102" ref-type="bibr">112</xref>]. The UV irradiation of some thiophenes also showed increased cytotoxic activities [<xref rid="B113-molecules-25-04102" ref-type="bibr">113</xref>]; this might be due to their instable nature under UV radiation. Hence, the UV irradiation of polyacetylene and thiophene compounds can form free radicals that would induce cell death. Due to the ability to produce ROS after irradiation, these compounds can be used as an alternative PS from natural sources.</p></sec><sec id="sec5dot3-molecules-25-04102"><title>5.3. Curcumins </title><p>Curcumin (CU) is a plant-based therapeutic compound isolated from rhizome of <italic>Curcuma longa</italic> of the Zingiberaceae family. Curcuminoid is one of the most extensively studied plant-derived bioactive compounds [<xref rid="B114-molecules-25-04102" ref-type="bibr">114</xref>]. Since the 1980s, the photobiological potential of CU was of great interest [<xref rid="B115-molecules-25-04102" ref-type="bibr">115</xref>,<xref rid="B116-molecules-25-04102" ref-type="bibr">116</xref>], and studies described CU as a desirable, highly promising photosensitiser [<xref rid="B115-molecules-25-04102" ref-type="bibr">115</xref>,<xref rid="B117-molecules-25-04102" ref-type="bibr">117</xref>,<xref rid="B118-molecules-25-04102" ref-type="bibr">118</xref>,<xref rid="B119-molecules-25-04102" ref-type="bibr">119</xref>,<xref rid="B120-molecules-25-04102" ref-type="bibr">120</xref>,<xref rid="B121-molecules-25-04102" ref-type="bibr">121</xref>]. The foremost property of CU is that it is biologically safe even at higher doses, and it can be easily produced on a large scale [<xref rid="B117-molecules-25-04102" ref-type="bibr">117</xref>,<xref rid="B122-molecules-25-04102" ref-type="bibr">122</xref>]. The photobleaching analysis reported the degradation profile of curcumin derivatives and its ability to produce singlet oxygen species [<xref rid="B123-molecules-25-04102" ref-type="bibr">123</xref>]. CU was characterised by an absorption spectrum of 300&#x02013;500 nm with a high extinction coefficient. This suggests that CU can induce a strong phototoxic reaction even at lower concentrations [<xref rid="B124-molecules-25-04102" ref-type="bibr">124</xref>,<xref rid="B125-molecules-25-04102" ref-type="bibr">125</xref>,<xref rid="B126-molecules-25-04102" ref-type="bibr">126</xref>]. Curcumin is considered as a potential anticancer agent and inhibits cancer cell proliferation in breast, lung, colon, kidney, ovary, and liver cancers [<xref rid="B114-molecules-25-04102" ref-type="bibr">114</xref>]. The in vitro and in vivo anticancer activity of curcumin has been proved by inhibition of various transcription factors such as NF-&#x003ba;B, AP-1, VEGF, iNOS, COX-2, 5-LOX, MMP-2, MMP-9 and IL-8, which are mainly responsible for angiogenesis and tumour growth [<xref rid="B127-molecules-25-04102" ref-type="bibr">127</xref>,<xref rid="B128-molecules-25-04102" ref-type="bibr">128</xref>]. The administration of curcumin significantly reduced the expression of the CDK4/cylin D1 complex by inhibiting p53 expression and causing the apoptotic process by inducing ROS generation. Furthermore, the enhanced antitumour activity was noted after UVB irradiation of curcumin by caspase activation on HaCaT (human keratinocyte cell) cells. It was also efficient against MCF-7 breast cancer cells at 30 J/cm<sup>2</sup> [<xref rid="B77-molecules-25-04102" ref-type="bibr">77</xref>,<xref rid="B78-molecules-25-04102" ref-type="bibr">78</xref>]. These data suggested that curcumin may act as a potent anticancer agent by preventing cancer progression, migration and invasion [<xref rid="B129-molecules-25-04102" ref-type="bibr">129</xref>,<xref rid="B130-molecules-25-04102" ref-type="bibr">130</xref>,<xref rid="B131-molecules-25-04102" ref-type="bibr">131</xref>]. Dovigo et al. [<xref rid="B132-molecules-25-04102" ref-type="bibr">132</xref>] found the light absorption ability of CU in the range of 300 and 500 nm with a maximum absorption at 430 nm, which might support its usage as a PS. The ROS-inducing and anticancer ability of CU makes it a potent candidate as a natural PS [<xref rid="B133-molecules-25-04102" ref-type="bibr">133</xref>]. Nevertheless, Chan and Wu [<xref rid="B134-molecules-25-04102" ref-type="bibr">134</xref>] observed that the photoactive nature of CU on human epidermal A431 carcinoma cells and the higher amount of CU also affect the irradiation penetration [<xref rid="B132-molecules-25-04102" ref-type="bibr">132</xref>,<xref rid="B134-molecules-25-04102" ref-type="bibr">134</xref>,<xref rid="B135-molecules-25-04102" ref-type="bibr">135</xref>]. The irradiation of CU under a 290&#x02013;320 nm UVB light source with the fluence of 100 mJ/cm<sup>2</sup> induced apoptosis in HaCaT keratinocyte cells [<xref rid="B78-molecules-25-04102" ref-type="bibr">78</xref>]. Based on the above reports, CU can be used as a natural PS, and it can achieve high efficacy at a low concentration when combined with PDT. The existing PDT and photoactive reports on CU suggest that CU can be used as a potential and promising natural PS in PDT. In conclusion, CU can be a potent photosensitiser in the treatment of cancer and skin infections. Therefore, investigating the photodynamic potential of CU derivatives in terms of higher absorption and extinction coefficient will contribute to the increased efficacy of photodynamic toxicity.</p></sec><sec id="sec5dot4-molecules-25-04102"><title>5.4. Alkaloids</title><p>Alkaloids, a diverse secondary metabolites group from higher plants, contain a heterocyclic structure with a nitrogen atom in the ring [<xref rid="B136-molecules-25-04102" ref-type="bibr">136</xref>]. Nitrogen-containing alkaloids are normally photoactive in nature, e.g., quinine and cinchonamine. The alkaloids were reported for many significant properties, such as analgesic and anticancer activity [<xref rid="B136-molecules-25-04102" ref-type="bibr">136</xref>,<xref rid="B137-molecules-25-04102" ref-type="bibr">137</xref>,<xref rid="B138-molecules-25-04102" ref-type="bibr">138</xref>,<xref rid="B139-molecules-25-04102" ref-type="bibr">139</xref>]. The alkaloids camptothecin and vinblastine are few alkaloids were successfully utilised as chemotherapeutic drugs [<xref rid="B138-molecules-25-04102" ref-type="bibr">138</xref>,<xref rid="B140-molecules-25-04102" ref-type="bibr">140</xref>]. The anticancer activity of alkaloids was proved by different studies by means of disturbing tumour progression by induction of cell cycle arrest at the G1 or G2/M phases, regulating cyclin-dependent kinase (CDK) and promoting apoptosis as well as autophagy in tumour cells. Furthermore, these compounds induce apoptosis by regulating Bax, Bcl-2, Bcl-xL, NF-&#x003ba;B and various caspase proteins [<xref rid="B140-molecules-25-04102" ref-type="bibr">140</xref>,<xref rid="B141-molecules-25-04102" ref-type="bibr">141</xref>,<xref rid="B142-molecules-25-04102" ref-type="bibr">142</xref>,<xref rid="B143-molecules-25-04102" ref-type="bibr">143</xref>]. In addition, the combination of alkaloids with chemotherapeutic drugs and irradiation also enhanced the biological activities [<xref rid="B144-molecules-25-04102" ref-type="bibr">144</xref>,<xref rid="B145-molecules-25-04102" ref-type="bibr">145</xref>]. Furthermore, alkaloids induce the formation of intracellular ROS in cancer cells, which leads to the destruction of cancer cell metabolism [<xref rid="B140-molecules-25-04102" ref-type="bibr">140</xref>,<xref rid="B141-molecules-25-04102" ref-type="bibr">141</xref>,<xref rid="B142-molecules-25-04102" ref-type="bibr">142</xref>,<xref rid="B143-molecules-25-04102" ref-type="bibr">143</xref>]. The photochemically best-known alkaloid is berberine; Luiza Andreazza et al. [<xref rid="B146-molecules-25-04102" ref-type="bibr">146</xref>], Bhattacharyya et al. [<xref rid="B147-molecules-25-04102" ref-type="bibr">147</xref>] and Inbaraj et al. [<xref rid="B81-molecules-25-04102" ref-type="bibr">81</xref>] reported the antitumour activity of berberine upon UV and blue light irradiation. The irradiation of berberine at 410 nm proved to be effective in controlling brain cancer cell growth [<xref rid="B146-molecules-25-04102" ref-type="bibr">146</xref>]. Beta-carboline and harmine are also a noticeable alkaloid with a photoactive nature and are reported to produce a significant amount of ROS after irradiation [<xref rid="B148-molecules-25-04102" ref-type="bibr">148</xref>], which is considered an important feature of potent PSs. The photoactivity of harmine was proved by the UVA (long-wave ultraviolet radiation) irradiation against tumour cell lines [<xref rid="B148-molecules-25-04102" ref-type="bibr">148</xref>]. Berberine was extensively investigated as a potential photosensitising agent for PDT [<xref rid="B149-molecules-25-04102" ref-type="bibr">149</xref>,<xref rid="B150-molecules-25-04102" ref-type="bibr">150</xref>,<xref rid="B151-molecules-25-04102" ref-type="bibr">151</xref>]. The fluorescent active nature of berberine is indicated for its efficiency in PDT [<xref rid="B149-molecules-25-04102" ref-type="bibr">149</xref>]; thus, berberine and its associated alkaloids can be used as a new candidate for photodynamic therapy [<xref rid="B150-molecules-25-04102" ref-type="bibr">150</xref>]. Different studies have proved the photosensitising as well as ROS generation ability of alkaloids in the presence of a light source [<xref rid="B151-molecules-25-04102" ref-type="bibr">151</xref>]. Therefore, berberine can be studied as a natural photosensitiser in PDT applications with minimal side effects.</p></sec><sec id="sec5dot5-molecules-25-04102"><title>5.5. Anthraquinones (AQ)</title><p>Anthraquinone are the largest group among natural quinones from higher plants, which, including naphthoquinones and benzoquinones, includes over 700 compounds, including emodin, physcion, catenarin and rhein [<xref rid="B152-molecules-25-04102" ref-type="bibr">152</xref>,<xref rid="B153-molecules-25-04102" ref-type="bibr">153</xref>]. The hydroxylation pattern, however, dictates the possibility of AQs&#x02019; photopharmacological properties. Notably, AQs&#x02019; aminoanthraquinone derivatives were studied extensively for their photoactive properties among the plant compounds due to their UV/vis absorption and photosensitising nature [<xref rid="B154-molecules-25-04102" ref-type="bibr">154</xref>,<xref rid="B155-molecules-25-04102" ref-type="bibr">155</xref>]. The AQs were reported as kinase and tyrosinase inhibitors as well as cytotoxicity agents. The <italic>M. elliptica</italic> AQs such as morindone, soranjidiol and rubiadin were also reported for their antitumour activity against lymphocytic leukaemia (P-388) cells [<xref rid="B156-molecules-25-04102" ref-type="bibr">156</xref>]. The anthraquinones isolated from <italic>H. pustulata</italic> leaves and stem exhibited photosensitising properties by generation of singlet oxygen and/or superoxide anion radicals [<xref rid="B157-molecules-25-04102" ref-type="bibr">157</xref>]. Comini et al. [<xref rid="B158-molecules-25-04102" ref-type="bibr">158</xref>] reported that irradiation of AQs (soranjidiol and rubiadin) under visible radiation of 380&#x02013;480 nm can promote the anti-proliferative effect on MCF-7 breast cancer cells. In addition, Montoya et al. [<xref rid="B157-molecules-25-04102" ref-type="bibr">157</xref>] and Vittar et al. [<xref rid="B159-molecules-25-04102" ref-type="bibr">159</xref>] also reported photosensitisation effects of AQs in Balb/c mice and their leukocyte-inhibiting ability in a dose-dependent manner by inducing apoptosis, necrosis, or autophagy. These study results show the photoactive nature of AQs to inhibit the proliferation of cancerous cells. Based on the previous studies and the above data, molecular targets responsible for the anticancer activity of AQs and major phytocompounds are summarised in <xref ref-type="fig" rid="molecules-25-04102-f004">Figure 4</xref>.</p></sec></sec><sec id="sec6-molecules-25-04102"><title>6. Theorical Studies for Assessing the Photoactivity of Natural Compounds</title><p>The development of various antitumor compounds with different molecular targets initiated an exciting field of investigation with recently developed theoretical studies. The theoretical studies including density functional theory (DFT) and time-dependent density functional theory (TD-DFT) were used to assess a series of photophysical properties, including absorption spectra, excitation energies (singlet and triplet) and spin&#x02013;orbit matrix elements. All the reported compounds are potential UVA chemotherapeutic agents which require the lowest triplet-state energy for producing highly cytotoxic ROS [<xref rid="B160-molecules-25-04102" ref-type="bibr">160</xref>,<xref rid="B161-molecules-25-04102" ref-type="bibr">161</xref>].</p></sec><sec id="sec7-molecules-25-04102"><title>7. Advantages and Scope of Natural PSs</title><p>The anticancer property of many plant extracts and bioactive compounds have been analysed, but not so much in terms of as sources of photosensitisers. Selecting proper PSs is the first step in PDT, and, to date, only a few PSs are clinically approved, such as Photofrin, Foscan and Levulan. The present study explored the common photoactive nature of various phytocompounds. Many of the natural photoactive compounds were reported for their non-toxicity against normal cells and toxicity towards cancer cells. The important property of a PS is the nontoxic nature during the absence of light. The increasing activity of extracts or phytocompounds after irradiation by light makes them good photosensitising candidates for PDT. Another important feature that makes photoactive plant compounds suitable photosensitisers is their absorption maxima at 400&#x02013;700 nm, which is biologically compatible. The selective nature of these compounds is important in clinical PDT to overcome side effects. Future studies are warranted to isolate and evaluate these specific photoactive compounds from plants to be used as a potent PSs for PDT for cancer and related disorders [<xref rid="B162-molecules-25-04102" ref-type="bibr">162</xref>,<xref rid="B163-molecules-25-04102" ref-type="bibr">163</xref>].</p></sec><sec sec-type="conclusions" id="sec8-molecules-25-04102"><title>8. Conclusions and Future Perspectives</title><p>As discussed in this review, plant-based photoactive compounds can be used as a natural PSs in PDT application. There are wide range of unknown natural compounds with different photoactive and phototoxic properties. This review summarises and encourages researchers to identify and elucidate natural photoactive plant-based compounds and to use them as alternatives for the synthesis PSs for a better PDT outcome. Furthermore, discovering natural phototoxic agents as PSs will be helpful to reduce toxicity and side effects and improve selectivity. In conclusion, use the plant-based PSs in PDT typically causes less and minimal adverse effects than other treatments that are commonly used in cancer therapies.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors sincerely thank the Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India and the Laser research centre, University of Johannesburg, South Africa for their support.</p></ack><notes><title>Author Contributions</title><p>Conceptualisation and writing, K.M.; review and editing, K.M., B.G., T.P. and H.A.; supervision, B.G., T.P. and H.A. The final version of the submitted manuscript was read and agreed by all the authors. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work is supported by Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India in the form of SERB&#x02014;Overseas Visiting Doctoral Fellowship (ODF/2018/000072). This work is also based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No. 98337). </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-04102"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Hussein</surname><given-names>A.</given-names></name><name><surname>Harith</surname><given-names>M.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Assessment of DNA Damage after Photodynamic Therapy Using a Metallophthalocyanine Photosensitizer</article-title><source>Int. J. Photoenergy</source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2012/281068</pub-id></element-citation></ref><ref id="B2-molecules-25-04102"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Klug</surname><given-names>W.S.</given-names></name><name><surname>Cummings</surname><given-names>M.R.</given-names></name><name><surname>Spencer</surname><given-names>C.A.</given-names></name></person-group><source>Concepts of Genetics</source><edition>8th ed.</edition><publisher-name>Pearson Education International</publisher-name><publisher-loc>Upper Saddle River, NJ, USA</publisher-loc><year>2006</year></element-citation></ref><ref id="B3-molecules-25-04102"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mat&#x000e9;s</surname><given-names>J.M.</given-names></name><name><surname>Segura</surname><given-names>J.A.</given-names></name><name><surname>Alonso</surname><given-names>F.J.</given-names></name><name><surname>M&#x000e1;rquez</surname><given-names>J.D.</given-names></name></person-group><article-title>Intracellular redox status and oxidative stress: Implications for cell proliferation, apoptosis, and carcinogenesis</article-title><source>Arch. Toxicol.</source><year>2008</year><volume>82</volume><fpage>273</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1007/s00204-008-0304-z</pub-id><?supplied-pmid 18443763?><pub-id pub-id-type="pmid">18443763</pub-id></element-citation></ref><ref id="B4-molecules-25-04102"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago-Montero</surname><given-names>R.</given-names></name><name><surname>Sossa-Azuela</surname><given-names>H.</given-names></name><name><surname>Guti&#x000e9;rrez-Hern&#x000e1;ndez</surname><given-names>D.</given-names></name><name><surname>Zamudio</surname><given-names>V.</given-names></name><name><surname>Hern&#x000e1;ndez-Bautista</surname><given-names>I.</given-names></name><name><surname>Valadez-God&#x000ed;nez</surname><given-names>S.</given-names></name></person-group><article-title>Novel Mathematical Model of Breast Cancer Diagnostics Using an Associative Pattern Classification</article-title><source>Diagnostics</source><year>2020</year><volume>10</volume><elocation-id>136</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics10030136</pub-id><?supplied-pmid 32121569?><pub-id pub-id-type="pmid">32121569</pub-id></element-citation></ref><ref id="B5-molecules-25-04102"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Nie</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.S.</given-names></name></person-group><article-title>Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy</article-title><source>Chem. Soc. Rev.</source><year>2016</year><volume>45</volume><fpage>6597</fpage><lpage>6626</lpage><pub-id pub-id-type="doi">10.1039/C6CS00271D</pub-id><?supplied-pmid 27722328?><pub-id pub-id-type="pmid">27722328</pub-id></element-citation></ref><ref id="B6-molecules-25-04102"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baskaran</surname><given-names>R.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>S.-G.</given-names></name></person-group><article-title>Clinical development of photodynamic agents and therapeutic applications</article-title><source>Biomater. Res.</source><year>2018</year><volume>22</volume><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/s40824-018-0140-z</pub-id><?supplied-pmid 30275968?><pub-id pub-id-type="pmid">30275968</pub-id></element-citation></ref><ref id="B7-molecules-25-04102"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida</surname><given-names>D.R.Q.</given-names></name><name><surname>Terra</surname><given-names>L.F.</given-names></name><name><surname>Labriola</surname><given-names>L.</given-names></name><name><surname>Dos Santos</surname><given-names>A.F.</given-names></name><name><surname>Baptista</surname><given-names>M.S.</given-names></name></person-group><article-title>Photodynamic therapy in cancer treatment&#x02014;An update review</article-title><source>J. Cancer Metastasis Treat.</source><year>2019</year><volume>2019</volume><fpage>10</fpage><lpage>20517</lpage><pub-id pub-id-type="doi">10.20517/2394-4722.2018.83</pub-id></element-citation></ref><ref id="B8-molecules-25-04102"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>K.</given-names></name><name><surname>Khachemoune</surname><given-names>A.</given-names></name></person-group><article-title>An update on topical photodynamic therapy for clinical dermatologists</article-title><source>J. Dermatol. Treat.</source><year>2019</year><volume>30</volume><fpage>732</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1080/09546634.2019.1569752</pub-id></element-citation></ref><ref id="B9-molecules-25-04102"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasi</surname><given-names>M.A.</given-names></name><name><surname>Pagliara</surname><given-names>M.M.</given-names></name><name><surname>Lanza</surname><given-names>A.</given-names></name><name><surname>Sammarco</surname><given-names>M.G.</given-names></name><name><surname>Caputo</surname><given-names>C.G.</given-names></name><name><surname>Grimaldi</surname><given-names>G.</given-names></name><name><surname>Scupola</surname><given-names>A.</given-names></name></person-group><article-title>Photodynamic Therapy in Ocular Oncology</article-title><source>Biomedicines</source><year>2018</year><volume>6</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines6010017</pub-id></element-citation></ref><ref id="B10-molecules-25-04102"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y.M.</given-names></name><name><surname>Adelzadeh</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>J.J.</given-names></name></person-group><article-title>Photodynamic therapy for psoriasis</article-title><source>J. Dermatol. Treat.</source><year>2014</year><volume>26</volume><fpage>202</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.3109/09546634.2014.927816</pub-id></element-citation></ref><ref id="B11-molecules-25-04102"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>A.M.</given-names></name><name><surname>Siopa</surname><given-names>J.R.</given-names></name><name><surname>Martins-Gomes</surname><given-names>C.</given-names></name><name><surname>Teixeira</surname><given-names>M.D.C.</given-names></name><name><surname>Santos</surname><given-names>D.J.</given-names></name><name><surname>Pires</surname><given-names>M.D.A.</given-names></name><name><surname>Andreani</surname><given-names>T.</given-names></name></person-group><article-title>New strategies for the treatment of autoimmune diseases using nanotechnologies</article-title><source>Emerg. Nanotechnol. Immunol.</source><year>2018</year><fpage>135</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/b978-0-323-40016-9.00006-3</pub-id></element-citation></ref><ref id="B12-molecules-25-04102"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatz</surname><given-names>K.</given-names></name><name><surname>Schneider</surname><given-names>U.</given-names></name><name><surname>Henrich</surname><given-names>P.B.</given-names></name><name><surname>Braun</surname><given-names>B.</given-names></name><name><surname>Sacu</surname><given-names>S.</given-names></name></person-group><article-title>Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study</article-title><source>Ophthalmologia</source><year>2014</year><volume>233</volume><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1159/000367603</pub-id><?supplied-pmid 25471330?><pub-id pub-id-type="pmid">25471330</pub-id></element-citation></ref><ref id="B13-molecules-25-04102"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oniszczuk</surname><given-names>A.</given-names></name><name><surname>Wojtunik-Kulesza</surname><given-names>K.A.</given-names></name><name><surname>Oniszczuk</surname><given-names>T.</given-names></name><name><surname>Kasprzak</surname><given-names>K.</given-names></name></person-group><article-title>The potential of photodynamic therapy (PDT)&#x02014;Experimental investigations and clinical use</article-title><source>Biomed. Pharmacother.</source><year>2016</year><volume>83</volume><fpage>912</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.07.058</pub-id><?supplied-pmid 27522005?><pub-id pub-id-type="pmid">27522005</pub-id></element-citation></ref><ref id="B14-molecules-25-04102"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Longo</surname><given-names>J.P.F.</given-names></name><name><surname>Azevedo</surname><given-names>R.B.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Muehlmann</surname><given-names>L.A.</given-names></name></person-group><article-title>An updated overview on the development of new photosensitizers for anticancer photodynamic therapy</article-title><source>Acta Pharm. Sin. B</source><year>2017</year><volume>8</volume><fpage>137</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2017.09.003</pub-id><?supplied-pmid 29719775?><pub-id pub-id-type="pmid">29719775</pub-id></element-citation></ref><ref id="B15-molecules-25-04102"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granelli</surname><given-names>S.G.</given-names></name><name><surname>Diamond</surname><given-names>I.</given-names></name><name><surname>McDonagh</surname><given-names>A.F.</given-names></name><name><surname>Wilson</surname><given-names>C.B.</given-names></name><name><surname>Nielsen</surname><given-names>S.L.</given-names></name></person-group><article-title>Photochemotherapy of glioma cells by visible light and hematoporphyrin</article-title><source>Cancer Res.</source><year>1975</year><volume>35</volume><fpage>2567</fpage><lpage>2570</lpage><pub-id pub-id-type="pmid">1149051</pub-id></element-citation></ref><ref id="B16-molecules-25-04102"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abrahamse</surname><given-names>H.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><source>Photomedicine and Stem Cells: The Janus Face of Photodynamic Therapy (PDT) to Kill Cancer Stem Cells, and Photobiomodulation (PBM) to Stimulate Normal Stem Cells</source><publisher-name>Morgan &#x00026; Claypool Publishers</publisher-name><publisher-loc>Bristol, UK</publisher-loc><year>2017</year></element-citation></ref><ref id="B17-molecules-25-04102"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>L.M.</given-names></name><name><surname>Dos Santos</surname><given-names>F.V.</given-names></name><name><surname>Lyon</surname><given-names>J.P.</given-names></name><name><surname>Maftoum-Costa</surname><given-names>M.</given-names></name><name><surname>Soares</surname><given-names>C.P.</given-names></name><name><surname>Da Silva</surname><given-names>N.S.</given-names></name></person-group><article-title>Photodynamic Therapy: Porphyrins and Phthalocyanines as Photosensitizers</article-title><source>Aust. J. Chem.</source><year>2008</year><volume>61</volume><fpage>741</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1071/CH08145</pub-id></element-citation></ref><ref id="B18-molecules-25-04102"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>A.</given-names></name><name><surname>Mansoori</surname><given-names>B.</given-names></name><name><surname>Baradaran</surname><given-names>B.</given-names></name></person-group><article-title>Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies</article-title><source>Biomed. Pharmacother.</source><year>2017</year><volume>86</volume><fpage>262</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.023</pub-id><pub-id pub-id-type="pmid">28006752</pub-id></element-citation></ref><ref id="B19-molecules-25-04102"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>A.</given-names></name><name><surname>Mansoori</surname><given-names>B.</given-names></name><name><surname>Aghapour</surname><given-names>M.</given-names></name><name><surname>Baradaran</surname><given-names>B.</given-names></name></person-group><article-title>Urtica dioica dichloromethane extract induce apoptosis from intrinsic pathway on human prostate cancer cells (PC3)</article-title><source>Cell. Mol. Boil.</source><year>2016</year><volume>62</volume><fpage>78</fpage><lpage>83</lpage></element-citation></ref><ref id="B20-molecules-25-04102"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>A.</given-names></name><name><surname>Mansoori</surname><given-names>B.</given-names></name><name><surname>Goldar</surname><given-names>S.</given-names></name><name><surname>Shanehbandi</surname><given-names>D.</given-names></name><name><surname>Khaze</surname><given-names>V.</given-names></name><name><surname>Mohammadnejad</surname><given-names>L.</given-names></name><name><surname>Baghbani</surname><given-names>E.</given-names></name><name><surname>Baradaran</surname><given-names>B.</given-names></name></person-group><article-title>Effects of Urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-MB-468)</article-title><source>Cell. Mol. Boil.</source><year>2016</year><volume>62</volume><fpage>62</fpage><lpage>67</lpage></element-citation></ref><ref id="B21-molecules-25-04102"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alali</surname><given-names>F.Q.</given-names></name><name><surname>Tawaha</surname><given-names>K.</given-names></name></person-group><article-title>Dereplication of bioactive constituents of the genus hypericum using LC-(+,&#x02212;)-ESI-MS and LC-PDA techniques: Hypericum triquterifolium as a case study</article-title><source>Saudi Pharm. J.</source><year>2009</year><volume>17</volume><fpage>269</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2009.10.002</pub-id><pub-id pub-id-type="pmid">23960710</pub-id></element-citation></ref><ref id="B22-molecules-25-04102"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>C.</given-names></name></person-group><article-title>Ready for a comeback of natural products in oncology</article-title><source>Biochem. Pharmacol.</source><year>2009</year><volume>77</volume><fpage>1447</fpage><lpage>1457</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2008.12.013</pub-id><pub-id pub-id-type="pmid">19161987</pub-id></element-citation></ref><ref id="B23-molecules-25-04102"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>B.B.</given-names></name><name><surname>Tiwari</surname><given-names>V.K.</given-names></name></person-group><article-title>Natural products: An evolving role in future drug discovery</article-title><source>Eur. J. Med. Chem.</source><year>2011</year><volume>46</volume><fpage>4769</fpage><lpage>4807</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2011.07.057</pub-id><?supplied-pmid 21889825?><pub-id pub-id-type="pmid">21889825</pub-id></element-citation></ref><ref id="B24-molecules-25-04102"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>M.C.</given-names></name></person-group><article-title>Photodynamic Therapy Based on Arrabidaea chica (Crajiru) Extract Nanoemulsion: In vitro Activity against Monolayers and Spheroids of Human Mammary Adenocarcinoma MCF-7 Cells</article-title><source>J. Nanomed. Nanotechnol.</source><year>2015</year><volume>6</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.4172/2157-7439.1000286</pub-id></element-citation></ref><ref id="B25-molecules-25-04102"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>P.J.</given-names></name><name><surname>Appleton</surname><given-names>D.R.</given-names></name><name><surname>Mustafa</surname><given-names>M.R.</given-names></name><name><surname>Lee</surname><given-names>H.B.</given-names></name></person-group><article-title>Rapid Identification of Cyclic Tetrapyrrolic Photosensitisers for Photodynamic Therapy Using On-line Hyphenated LC-PDA-MS Coupled with Photo-cytotoxicity Assay</article-title><source>Phytochem. Anal.</source><year>2011</year><volume>23</volume><fpage>52</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1002/pca.1324</pub-id><pub-id pub-id-type="pmid">21692117</pub-id></element-citation></ref><ref id="B26-molecules-25-04102"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skalkos</surname><given-names>D.</given-names></name><name><surname>Gioti</surname><given-names>E.</given-names></name><name><surname>Stalikas</surname><given-names>C.</given-names></name><name><surname>Meyer</surname><given-names>H.</given-names></name><name><surname>Papazoglou</surname><given-names>T.</given-names></name><name><surname>Filippidis</surname><given-names>G.</given-names></name><name><surname>Papazoglou</surname><given-names>T.G.</given-names></name></person-group><article-title>Photophysical properties of Hypericum perforatum L. extracts&#x02014;Novel photosensitizers for PDT</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2006</year><volume>82</volume><fpage>146</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2005.11.001</pub-id><?supplied-pmid 16388961?><pub-id pub-id-type="pmid">16388961</pub-id></element-citation></ref><ref id="B27-molecules-25-04102"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeisser-Labou&#x000e8;be</surname><given-names>M.</given-names></name><name><surname>Lange</surname><given-names>N.</given-names></name><name><surname>Gurny</surname><given-names>R.</given-names></name><name><surname>Delie</surname><given-names>F.</given-names></name></person-group><article-title>Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer</article-title><source>Int. J. Pharm.</source><year>2006</year><volume>326</volume><fpage>174</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2006.07.012</pub-id><?supplied-pmid 16930882?><pub-id pub-id-type="pmid">16930882</pub-id></element-citation></ref><ref id="B28-molecules-25-04102"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirmalek</surname><given-names>S.A.</given-names></name><name><surname>Azizi</surname><given-names>M.A.</given-names></name><name><surname>Jangholi</surname><given-names>E.</given-names></name><name><surname>Yadollah-Damavandi</surname><given-names>S.</given-names></name><name><surname>Javidi</surname><given-names>M.A.</given-names></name><name><surname>Parsa</surname><given-names>Y.</given-names></name><name><surname>Parsa</surname><given-names>T.</given-names></name><name><surname>Salimi-Tabatabaee</surname><given-names>S.A.</given-names></name><name><surname>Kolagar</surname><given-names>H.G.</given-names></name><name><surname>Alizadeh-Navaei</surname><given-names>R.</given-names></name></person-group><article-title>Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line</article-title><source>Cancer Cell Int.</source><year>2016</year><volume>16</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/s12935-016-0279-4</pub-id><pub-id pub-id-type="pmid">26865836</pub-id></element-citation></ref><ref id="B29-molecules-25-04102"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonar</surname><given-names>D.</given-names></name><name><surname>S&#x000fc;lo&#x0011f;lu</surname><given-names>A.K.</given-names></name><name><surname>Selmano&#x0011f;lu</surname><given-names>G.</given-names></name><name><surname>S&#x000fc;nnet&#x000e7;io&#x0011f;lu</surname><given-names>M.M.</given-names></name></person-group><article-title>An Electron paramagnetic resonance (EPR) spin labeling study in HT-29 Colon adenocarcinoma cells after Hypericin-mediated photodynamic therapy</article-title><source>BMC Mol. Cell Boil.</source><year>2019</year><volume>20</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s12860-019-0205-4</pub-id></element-citation></ref><ref id="B30-molecules-25-04102"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Ichikawa</surname><given-names>H.</given-names></name><name><surname>Garodia</surname><given-names>P.</given-names></name><name><surname>Weerasinghe</surname><given-names>P.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Bhatt</surname><given-names>I.D.</given-names></name><name><surname>Pandey</surname><given-names>M.K.</given-names></name><name><surname>Shishodia</surname><given-names>S.</given-names></name><name><surname>Nair</surname><given-names>M.G.</given-names></name></person-group><article-title>From traditional Ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer</article-title><source>Expert Opin. Ther. Targets</source><year>2006</year><volume>10</volume><fpage>87</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1517/14728222.10.1.87</pub-id><pub-id pub-id-type="pmid">16441231</pub-id></element-citation></ref><ref id="B31-molecules-25-04102"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>V.K.</given-names></name></person-group><article-title>Therapeutic and pharmacological aspects of photodynamic product chlorophyllin</article-title><source>Eur. J. Biol. Res.</source><year>2019</year><volume>9</volume><fpage>64</fpage><lpage>76</lpage></element-citation></ref><ref id="B32-molecules-25-04102"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juzeniene</surname><given-names>A.</given-names></name><name><surname>Nielsen</surname><given-names>K.P.</given-names></name><name><surname>Moan</surname><given-names>J.</given-names></name></person-group><article-title>Biophysical Aspects of Photodynamic Therapy</article-title><source>J. Environ. Pathol. Toxicol. Oncol.</source><year>2006</year><volume>25</volume><fpage>7</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1615/JEnvironPatholToxicolOncol.v25.i1-2.20</pub-id><pub-id pub-id-type="pmid">16566708</pub-id></element-citation></ref><ref id="B33-molecules-25-04102"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>B.P.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>A Review on Novel Breast Cancer Therapies: Photodynamic Therapy and Plant Derived Agent Induced Cell Death Mechanisms</article-title><source>Anti-Cancer Agents Med. Chem.</source><year>2016</year><volume>15</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.2174/1871520615666151026094028</pub-id></element-citation></ref><ref id="B34-molecules-25-04102"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aniogo</surname><given-names>E.C.</given-names></name><name><surname>George</surname><given-names>B.P.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>The role of photodynamic therapy on multidrug resistant breast cancer</article-title><source>Cancer Cell Int.</source><year>2019</year><volume>19</volume><fpage>91</fpage><pub-id pub-id-type="doi">10.1186/s12935-019-0815-0</pub-id><?supplied-pmid 31007609?><pub-id pub-id-type="pmid">31007609</pub-id></element-citation></ref><ref id="B35-molecules-25-04102"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>R.R.</given-names></name><name><surname>Sibata</surname><given-names>C.H.</given-names></name></person-group><article-title>Oncologic photodynamic therapy photosensitizers: A clinical review</article-title><source>Photodiagn. Photodyn. Ther.</source><year>2010</year><volume>7</volume><fpage>61</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2010.02.001</pub-id><?supplied-pmid 20510301?><pub-id pub-id-type="pmid">20510301</pub-id></element-citation></ref><ref id="B36-molecules-25-04102"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.</given-names></name><name><surname>Roskams</surname><given-names>T.</given-names></name><name><surname>De Witte</surname><given-names>P.A.M.</given-names></name></person-group><article-title>Antivascular tumor eradication by hypericin-mediated photodynamic therapy</article-title><source>Photochem. Photobiol.</source><year>2002</year><volume>76</volume><fpage>509</fpage><pub-id pub-id-type="doi">10.1562/0031-8655(2002)076&#x0003c;0509:ATEBHM&#x0003e;2.0.CO;2</pub-id><pub-id pub-id-type="pmid">12462645</pub-id></element-citation></ref><ref id="B37-molecules-25-04102"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascencio</surname><given-names>M.</given-names></name><name><surname>Collinet</surname><given-names>P.</given-names></name><name><surname>Farine</surname><given-names>M.</given-names></name><name><surname>Mordon</surname><given-names>S.</given-names></name></person-group><article-title>Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy</article-title><source>Lasers Surg. Med.</source><year>2008</year><volume>40</volume><fpage>332</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1002/lsm.20629</pub-id><pub-id pub-id-type="pmid">18563777</pub-id></element-citation></ref><ref id="B38-molecules-25-04102"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A.D.</given-names></name><name><surname>Nowis</surname><given-names>D.</given-names></name><name><surname>Golab</surname><given-names>J.</given-names></name><name><surname>Vandenabeele</surname><given-names>P.</given-names></name><name><surname>Krysko</surname><given-names>D.V.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name></person-group><article-title>Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation</article-title><source>Biochim. Biophys. Acta (BBA) Rev. Cancer</source><year>2010</year><volume>1805</volume><fpage>53</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.bbcan.2009.08.003</pub-id></element-citation></ref><ref id="B39-molecules-25-04102"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castano</surname><given-names>A.P.</given-names></name><name><surname>Demidova</surname><given-names>T.N.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><article-title>Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction</article-title><source>Photodiagn. Photodyn. Ther.</source><year>2005</year><volume>2</volume><fpage>91</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S1572-1000(05)00060-8</pub-id></element-citation></ref><ref id="B40-molecules-25-04102"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogilby</surname><given-names>P.R.</given-names></name></person-group><article-title>Singlet oxygen: There is indeed something new under the sun</article-title><source>Chem. Soc. Rev.</source><year>2010</year><volume>39</volume><fpage>3181</fpage><pub-id pub-id-type="doi">10.1039/b926014p</pub-id><pub-id pub-id-type="pmid">20571680</pub-id></element-citation></ref><ref id="B41-molecules-25-04102"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oseroff</surname><given-names>A.R.</given-names></name><name><surname>Blumenson</surname><given-names>L.R.</given-names></name><name><surname>Wilson</surname><given-names>B.D.</given-names></name><name><surname>Mang</surname><given-names>T.S.</given-names></name><name><surname>Bellnier</surname><given-names>D.A.</given-names></name><name><surname>Parsons</surname><given-names>J.C.</given-names></name><name><surname>Frawley</surname><given-names>N.</given-names></name><name><surname>Cooper</surname><given-names>M.</given-names></name><name><surname>Zeitouni</surname><given-names>N.</given-names></name><name><surname>Dougherty</surname><given-names>T.J.</given-names></name></person-group><article-title>A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin<sup>&#x000ae;</sup>) for treatment of basal cell carcinoma</article-title><source>Lasers Surg. Med.</source><year>2006</year><volume>38</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1002/lsm.20363</pub-id><pub-id pub-id-type="pmid">16788928</pub-id></element-citation></ref><ref id="B42-molecules-25-04102"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juzeniene</surname><given-names>A.</given-names></name><name><surname>Juzenas</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>L.-W.</given-names></name><name><surname>Iani</surname><given-names>V.</given-names></name><name><surname>Moan</surname><given-names>J.</given-names></name></person-group><article-title>Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy</article-title><source>Lasers Med. Sci.</source><year>2004</year><volume>19</volume><fpage>139</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1007/s10103-004-0314-x</pub-id><pub-id pub-id-type="pmid">15503248</pub-id></element-citation></ref><ref id="B43-molecules-25-04102"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>P.</given-names></name></person-group><article-title>Methyl aminolaevulinate&#x02013;photodynamic therapy: A review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer</article-title><source>Yearb. Dermatol. Dermatol. Surg.</source><year>2008</year><volume>2008</volume><fpage>322</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/S0093-3619(08)70931-6</pub-id></element-citation></ref><ref id="B44-molecules-25-04102"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffes</surname><given-names>E.W.</given-names></name><name><surname>McCullough</surname><given-names>J.L.</given-names></name><name><surname>Weinstein</surname><given-names>G.D.</given-names></name><name><surname>Kaplan</surname><given-names>R.</given-names></name><name><surname>Glazer</surname><given-names>S.D.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name></person-group><article-title>Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light</article-title><source>J. Am. Acad. Dermatol.</source><year>2001</year><volume>45</volume><fpage>96</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1067/mjd.2001.114288</pub-id><?supplied-pmid 11423841?><pub-id pub-id-type="pmid">11423841</pub-id></element-citation></ref><ref id="B45-molecules-25-04102"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>K.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name></person-group><article-title>A Chlorin-Based Nanoscale Metal&#x02013;Organic Framework for Photodynamic Therapy of Colon Cancers</article-title><source>J. Am. Chem. Soc.</source><year>2015</year><volume>137</volume><fpage>7600</fpage><lpage>7603</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b04069</pub-id><?supplied-pmid 26068094?><pub-id pub-id-type="pmid">26068094</pub-id></element-citation></ref><ref id="B46-molecules-25-04102"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C.M.</given-names></name><name><surname>Nathan</surname><given-names>T.</given-names></name><name><surname>Lees</surname><given-names>W.</given-names></name><name><surname>Mosse</surname><given-names>C.</given-names></name><name><surname>Freeman</surname><given-names>A.</given-names></name><name><surname>Emberton</surname><given-names>M.</given-names></name><name><surname>Bown</surname><given-names>S.</given-names></name></person-group><article-title>Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer</article-title><source>Lasers Surg. Med.</source><year>2006</year><volume>38</volume><fpage>356</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1002/lsm.20275</pub-id><pub-id pub-id-type="pmid">16392142</pub-id></element-citation></ref><ref id="B47-molecules-25-04102"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosjean</surname><given-names>P.</given-names></name><name><surname>Savary</surname><given-names>J.-F.</given-names></name><name><surname>Wagni&#x000e8;res</surname><given-names>G.</given-names></name><name><surname>Mizeret</surname><given-names>J.</given-names></name><name><surname>Woodtli</surname><given-names>A.</given-names></name><name><surname>Theumann</surname><given-names>J.-F.</given-names></name><name><surname>Fontolliet</surname><given-names>C.</given-names></name><name><surname>Bergh</surname><given-names>H.V.D.</given-names></name><name><surname>Monnier</surname><given-names>P.</given-names></name></person-group><article-title>Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers</article-title><source>Lasers Med. Sci.</source><year>1996</year><volume>11</volume><fpage>227</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1007/BF02134913</pub-id></element-citation></ref><ref id="B48-molecules-25-04102"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessel</surname><given-names>D.</given-names></name></person-group><article-title>Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>1997</year><volume>39</volume><fpage>81</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(96)00009-7</pub-id></element-citation></ref><ref id="B49-molecules-25-04102"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taber</surname><given-names>S.W.</given-names></name><name><surname>Fingar</surname><given-names>V.H.</given-names></name><name><surname>Coots</surname><given-names>C.T.</given-names></name><name><surname>Wieman</surname><given-names>T.J.</given-names></name></person-group><article-title>Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: A Phase I clinical study</article-title><source>Clin. Cancer Res.</source><year>1998</year><volume>4</volume><fpage>2741</fpage><lpage>2746</lpage><pub-id pub-id-type="pmid">9829737</pub-id></element-citation></ref><ref id="B50-molecules-25-04102"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagudaev</surname><given-names>D.M.</given-names></name></person-group><article-title>Sorokaty&#x0012d; Photodynamic therapy of prostatic adenoma</article-title><source>Urologiia</source><year>2007</year><volume>4</volume><fpage>34</fpage><lpage>37</lpage></element-citation></ref><ref id="B51-molecules-25-04102"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momma</surname><given-names>T.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name><name><surname>Wu</surname><given-names>H.C.</given-names></name><name><surname>Hasan</surname><given-names>T.</given-names></name></person-group><article-title>Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: Local control and distant metastasis</article-title><source>Cancer Res.</source><year>1998</year><volume>58</volume><fpage>5425</fpage><lpage>5431</lpage><pub-id pub-id-type="pmid">9850075</pub-id></element-citation></ref><ref id="B52-molecules-25-04102"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>J.G.</given-names></name><name><surname>Waterfield</surname><given-names>E.</given-names></name><name><surname>Richter</surname><given-names>A.M.</given-names></name><name><surname>Smits</surname><given-names>C.</given-names></name><name><surname>Lui</surname><given-names>H.</given-names></name><name><surname>Hruza</surname><given-names>L.</given-names></name><name><surname>Anderson</surname><given-names>R.R.</given-names></name><name><surname>Salvatori</surname><given-names>V.</given-names></name></person-group><article-title>Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A</article-title><source>Europto Biomedical Optics &#x02019;93</source><year>1994</year><volume>2078</volume><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1117/12.168659</pub-id></element-citation></ref><ref id="B53-molecules-25-04102"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>S.W.</given-names></name><name><surname>Woodburn</surname><given-names>K.W.</given-names></name><name><surname>Wright</surname><given-names>M.</given-names></name><name><surname>Mody</surname><given-names>T.D.</given-names></name><name><surname>Fan</surname><given-names>Q.</given-names></name><name><surname>Sessler</surname><given-names>J.L.</given-names></name><name><surname>Dow</surname><given-names>W.C.</given-names></name><name><surname>Miller</surname><given-names>R.A.</given-names></name></person-group><article-title>Lutetium Texaphyrin (PCI-0123): A Near-Infrared, Water-Soluble Photosensitizer</article-title><source>Photochem. Photobiol.</source><year>1996</year><volume>63</volume><fpage>892</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1996.tb09647.x</pub-id><pub-id pub-id-type="pmid">8992510</pub-id></element-citation></ref><ref id="B54-molecules-25-04102"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sessler</surname><given-names>J.L.</given-names></name><name><surname>Miller</surname><given-names>R.A.</given-names></name></person-group><article-title>Texaphyrins: New drugs with diverse clinical applications in radiation and photodynamic therapy</article-title><source>Biochem. Pharmacol.</source><year>2000</year><volume>59</volume><fpage>733</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/S0006-2952(99)00314-7</pub-id><pub-id pub-id-type="pmid">10718331</pub-id></element-citation></ref><ref id="B55-molecules-25-04102"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>K.</given-names></name><name><surname>Mick</surname><given-names>R.</given-names></name><name><surname>Busch</surname><given-names>T.</given-names></name><name><surname>Zhu</surname><given-names>T.C.</given-names></name><name><surname>Finlay</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Yodh</surname><given-names>A.</given-names></name><name><surname>Malkowicz</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Whittington</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer</article-title><source>Lasers Surg. Med.</source><year>2006</year><volume>38</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1002/lsm.20341</pub-id><?supplied-pmid 16788929?><pub-id pub-id-type="pmid">16788929</pub-id></element-citation></ref><ref id="B56-molecules-25-04102"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockson</surname><given-names>S.G.</given-names></name><name><surname>Lorenz</surname><given-names>D.P.</given-names></name><name><surname>Cheong</surname><given-names>W.-F.</given-names></name><name><surname>Woodburn</surname><given-names>K.W.</given-names></name></person-group><article-title>Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.102.5.591</pub-id><?supplied-pmid 10920074?><pub-id pub-id-type="pmid">10920074</pub-id></element-citation></ref><ref id="B57-molecules-25-04102"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kogias</surname><given-names>E.</given-names></name><name><surname>Vougioukas</surname><given-names>V.</given-names></name><name><surname>Hubbe</surname><given-names>U.</given-names></name><name><surname>Halatsch</surname><given-names>M.-E.</given-names></name></person-group><article-title>Minimally Invasive Approach for the Treatment of Lateral Lumbar Disc Herniations. Technique and Results</article-title><source>Minim. Invasive Neurosurg.</source><year>2007</year><volume>50</volume><fpage>160</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1055/s-2007-985143</pub-id><pub-id pub-id-type="pmid">17882752</pub-id></element-citation></ref><ref id="B58-molecules-25-04102"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>S.R.</given-names></name><name><surname>Holroyd</surname><given-names>J.A.</given-names></name><name><surname>Brown</surname><given-names>S.B.</given-names></name></person-group><article-title>The Subcellular Localization of Zn(ll) Phthalocyanines and Their Redistribution on Exposure to Light</article-title><source>Photochem. Photobiol.</source><year>1997</year><volume>65</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1997.tb08577.x</pub-id><?supplied-pmid 9077119?><pub-id pub-id-type="pmid">9077119</pub-id></element-citation></ref><ref id="B59-molecules-25-04102"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuchinskaya</surname><given-names>T.</given-names></name><name><surname>Moreno</surname><given-names>M.</given-names></name><name><surname>Cook</surname><given-names>M.J.</given-names></name><name><surname>Edwards</surname><given-names>D.R.</given-names></name><name><surname>Russell</surname><given-names>D.A.</given-names></name></person-group><article-title>Targeted photodynamic therapy of breast cancer cells using antibody&#x02013;phthalocyanine&#x02013;gold nanoparticle conjugates</article-title><source>Photochem. Photobiol. Sci.</source><year>2011</year><volume>10</volume><fpage>822</fpage><pub-id pub-id-type="doi">10.1039/c1pp05014a</pub-id><pub-id pub-id-type="pmid">21455532</pub-id></element-citation></ref><ref id="B60-molecules-25-04102"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekhejane</surname><given-names>P.R.</given-names></name><name><surname>Houreld</surname><given-names>N.N.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Multiorganelle Localization of Metallated Phthalocyanine Photosensitizer in Colorectal Cancer Cells (DLD-1 and CaCo-2) Enhances Efficacy of Photodynamic Therapy</article-title><source>Int. J. Photoenergy</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2014/383027</pub-id></element-citation></ref><ref id="B61-molecules-25-04102"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>D.W.C.</given-names></name></person-group><article-title>Rostaporfin (Miravant Medical Technologies)</article-title><source>IDrugs</source><year>2002</year><volume>5</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">12861479</pub-id></element-citation></ref><ref id="B62-molecules-25-04102"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>M.</given-names></name><name><surname>Somers</surname><given-names>R.H.</given-names></name><name><surname>Greenburg</surname><given-names>R.</given-names></name><name><surname>Ackler</surname><given-names>J.</given-names></name></person-group><article-title>Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: Case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2)</article-title><source>J. Surg. Oncol.</source><year>1998</year><volume>67</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9098(199802)67:2&#x0003c;121::AID-JSO9&#x0003e;3.0.CO;2-C</pub-id><pub-id pub-id-type="pmid">9486784</pub-id></element-citation></ref><ref id="B63-molecules-25-04102"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>S.H.</given-names></name><name><surname>Keck</surname><given-names>R.W.</given-names></name><name><surname>Hampton</surname><given-names>J.A.</given-names></name></person-group><article-title>Transperineal Photodynamic Ablation of the Canine Prostate</article-title><source>J. Urol.</source><year>1996</year><volume>156</volume><fpage>258</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(01)66012-9</pub-id><pub-id pub-id-type="pmid">8648818</pub-id></element-citation></ref><ref id="B64-molecules-25-04102"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name><name><surname>Cengel</surname><given-names>K.A.</given-names></name><name><surname>Foster</surname><given-names>T.H.</given-names></name><name><surname>Girotti</surname><given-names>A.W.</given-names></name><name><surname>Gollnick</surname><given-names>S.O.</given-names></name><name><surname>Hahn</surname><given-names>S.M.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name><name><surname>Juzeniene</surname><given-names>A.</given-names></name><name><surname>Kessel</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Photodynamic therapy of cancer: An update</article-title><source>CA Cancer J. Clin.</source><year>2011</year><volume>61</volume><fpage>250</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.3322/caac.20114</pub-id><?supplied-pmid 21617154?><pub-id pub-id-type="pmid">21617154</pub-id></element-citation></ref><ref id="B65-molecules-25-04102"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiners</surname><given-names>J.J.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name><name><surname>Oleinick</surname><given-names>N.L.</given-names></name><name><surname>Kessel</surname><given-names>D.</given-names></name></person-group><article-title>Assessing autophagy in the context of photodynamic therapy</article-title><source>Autophagy</source><year>2010</year><volume>6</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.4161/auto.6.1.10220</pub-id><?supplied-pmid 19855190?><pub-id pub-id-type="pmid">19855190</pub-id></element-citation></ref><ref id="B66-molecules-25-04102"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>C.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2628</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23102628</pub-id></element-citation></ref><ref id="B67-molecules-25-04102"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redmond</surname><given-names>R.W.</given-names></name><name><surname>Gamlin</surname><given-names>J.N.</given-names></name></person-group><article-title>A compilation of singlet oxygen yields from biologically relevant molecules</article-title><source>Photochem. Photobiol.</source><year>1999</year><volume>70</volume><fpage>391</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1999.tb08240.x</pub-id><pub-id pub-id-type="pmid">10546544</pub-id></element-citation></ref><ref id="B68-molecules-25-04102"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>N.</given-names></name><name><surname>Kohtani</surname><given-names>S.</given-names></name><name><surname>Nakagaki</surname><given-names>R.</given-names></name></person-group><article-title>Molecular aspects of furocoumarin reactions: Photophysics, photochemistry, photobiology, and structural analysis</article-title><source>J. Photochem. Photobiol. C Photochem. Rev.</source><year>2005</year><volume>6</volume><fpage>168</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochemrev.2005.08.002</pub-id></element-citation></ref><ref id="B69-molecules-25-04102"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fracarolli</surname><given-names>L.</given-names></name><name><surname>Rodrigues</surname><given-names>G.B.</given-names></name><name><surname>Pereira</surname><given-names>A.C.</given-names></name><name><surname>J&#x000fa;nior</surname><given-names>N.S.M.</given-names></name><name><surname>Silva-Junior</surname><given-names>G.J.</given-names></name><name><surname>Bachmann</surname><given-names>L.</given-names></name><name><surname>Wainwright</surname><given-names>M.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Braga</surname><given-names>G.U.</given-names></name></person-group><article-title>Inactivation of plant-pathogenic fungus Colletotrichum acutatum with natural plant-produced photosensitizers under solar radiation</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2016</year><volume>162</volume><fpage>402</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2016.07.009</pub-id></element-citation></ref><ref id="B70-molecules-25-04102"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobot</surname><given-names>V.</given-names></name><name><surname>Vytla&#x0010d;ilov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Kubicov&#x000e1;</surname><given-names>L.</given-names></name><name><surname>Opletal</surname><given-names>L.</given-names></name><name><surname>Jahod&#x000e1;&#x00159;</surname><given-names>L.</given-names></name><name><surname>Laakso</surname><given-names>I.</given-names></name><name><surname>Vuorela</surname><given-names>P.</given-names></name></person-group><article-title>Phototoxic activity of a thiophene polyacetylene from Leuzea carthamoides</article-title><source>Fitoterapia</source><year>2006</year><volume>77</volume><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2006.01.001</pub-id><pub-id pub-id-type="pmid">16488556</pub-id></element-citation></ref><ref id="B71-molecules-25-04102"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>B.</given-names></name><name><surname>Ag&#x000fc;ero</surname><given-names>M.B.</given-names></name><name><surname>Zygadlo</surname><given-names>J.</given-names></name><name><surname>Tapia</surname><given-names>A.</given-names></name><name><surname>Sol&#x000ed;s</surname><given-names>C.</given-names></name><name><surname>De Arias</surname><given-names>A.R.</given-names></name><name><surname>Yaluff</surname><given-names>G.</given-names></name><name><surname>Zacchino</surname><given-names>S.</given-names></name><name><surname>Feresin</surname><given-names>G.E.</given-names></name><name><surname>Schmeda-Hirschmann</surname><given-names>G.</given-names></name></person-group><article-title>Antimicrobial activity of extracts, essential oil and metabolites obtained from tagetes mendocina</article-title><source>J. Chil. Chem. Soc.</source><year>2009</year><volume>54</volume><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.4067/S0717-97072009000100016</pub-id></element-citation></ref><ref id="B72-molecules-25-04102"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Q.</given-names></name><name><surname>Lee</surname><given-names>J.W.</given-names></name><name><surname>Jang</surname><given-names>H.</given-names></name><name><surname>Choi</surname><given-names>J.E.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>N.</given-names></name><name><surname>Hong</surname><given-names>J.T.</given-names></name><name><surname>Lee</surname><given-names>M.K.</given-names></name><name><surname>Hwang</surname><given-names>B.Y.</given-names></name></person-group><article-title>Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>5995</fpage><lpage>5998</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.10.017</pub-id><pub-id pub-id-type="pmid">27865705</pub-id></element-citation></ref><ref id="B73-molecules-25-04102"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postigo</surname><given-names>A.</given-names></name><name><surname>Funes</surname><given-names>M.</given-names></name><name><surname>Petenatti</surname><given-names>E.</given-names></name><name><surname>Bottai</surname><given-names>H.</given-names></name><name><surname>Pacciaroni</surname><given-names>A.</given-names></name><name><surname>Sortino</surname><given-names>M.</given-names></name></person-group><article-title>Antifungal photosensitive activity of Porophyllum obscurum (Spreng.) DC.: Correlation of the chemical composition of the hexane extract with the bioactivity</article-title><source>Photodiagn. Photodyn. Ther.</source><year>2017</year><volume>20</volume><fpage>263</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2017.10.023</pub-id><?supplied-pmid 29111389?><pub-id pub-id-type="pmid">29111389</pub-id></element-citation></ref><ref id="B74-molecules-25-04102"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>S.R.M.</given-names></name><name><surname>Abdallah</surname><given-names>H.M.</given-names></name><name><surname>El Halawany</surname><given-names>A.M.</given-names></name><name><surname>Mohamed</surname><given-names>G.A.</given-names></name></person-group><article-title>Naturally occurring thiophenes: Isolation, purification, structural elucidation, and evaluation of bioactivities</article-title><source>Phytochem. Rev.</source><year>2015</year><volume>15</volume><fpage>197</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1007/s11101-015-9403-7</pub-id></element-citation></ref><ref id="B75-molecules-25-04102"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name></person-group><article-title>Photosensitizer effect of curcumin on UVB-irradiated HaCaT cells through activation of caspase pathways</article-title><source>Oncol. Rep.</source><year>2007</year><volume>17</volume><fpage>537</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.3892/or.17.3.537</pub-id><?supplied-pmid 17273730?><pub-id pub-id-type="pmid">17273730</pub-id></element-citation></ref><ref id="B76-molecules-25-04102"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.-Y.</given-names></name><name><surname>Lin</surname><given-names>J.-N.</given-names></name><name><surname>Ma</surname><given-names>J.-W.</given-names></name><name><surname>Yang</surname><given-names>N.-S.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Kuo</surname><given-names>S.-C.</given-names></name><name><surname>Way</surname><given-names>T.-D.</given-names></name></person-group><article-title>Demethoxycurcumin induces autophagic and apoptotic responses on breast cancer cells in photodynamic therapy</article-title><source>J. Funct. Foods</source><year>2015</year><volume>12</volume><fpage>439</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.jff.2014.12.014</pub-id></element-citation></ref><ref id="B77-molecules-25-04102"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randazzo</surname><given-names>W.</given-names></name><name><surname>Aznar</surname><given-names>R.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>G.</given-names></name></person-group><article-title>Curcumin-Mediated Photodynamic Inactivation of Norovirus Surrogates</article-title><source>Food Environ. Virol.</source><year>2016</year><volume>8</volume><fpage>244</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1007/s12560-016-9255-3</pub-id><pub-id pub-id-type="pmid">27496054</pub-id></element-citation></ref><ref id="B78-molecules-25-04102"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.-J.</given-names></name><name><surname>Kang</surname><given-names>S.-M.</given-names></name><name><surname>Jeong</surname><given-names>S.-H.</given-names></name><name><surname>Chung</surname><given-names>K.-H.</given-names></name><name><surname>Kim</surname><given-names>B.-I.</given-names></name></person-group><article-title>Antibacterial photodynamic therapy with curcumin and Curcuma xanthorrhiza extract against Streptococcus mutans</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2017</year><volume>20</volume><fpage>116</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2017.09.003</pub-id><pub-id pub-id-type="pmid">28890211</pub-id></element-citation></ref><ref id="B79-molecules-25-04102"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhavya</surname><given-names>M.</given-names></name><name><surname>Hebbar</surname><given-names>H.U.</given-names></name></person-group><article-title>Efficacy of blue LED in microbial inactivation: Effect of photosensitization and process parameters</article-title><source>Int. J. Food Microbiol.</source><year>2019</year><volume>290</volume><fpage>296</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2018.10.021</pub-id><pub-id pub-id-type="pmid">30414562</pub-id></element-citation></ref><ref id="B80-molecules-25-04102"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morten</surname><given-names>A.G.</given-names></name><name><surname>Martinez</surname><given-names>L.J.</given-names></name><name><surname>Holt</surname><given-names>N.</given-names></name><name><surname>Sik</surname><given-names>R.H.</given-names></name><name><surname>Reszka</surname><given-names>K.</given-names></name><name><surname>Chignell</surname><given-names>C.F.</given-names></name><name><surname>Tonnesen</surname><given-names>H.H.</given-names></name><name><surname>Roberts</surname><given-names>J.E.</given-names></name></person-group><article-title>Photophysical Studies on Antimalariai Drugs</article-title><source>Photochem. Photobiol.</source><year>2008</year><volume>69</volume><fpage>282</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1999.tb03287.x</pub-id></element-citation></ref><ref id="B81-molecules-25-04102"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inbaraj</surname><given-names>J.J.</given-names></name><name><surname>Kukielczak</surname><given-names>B.M.</given-names></name><name><surname>Bilski</surname><given-names>P.</given-names></name><name><surname>Sandvik</surname><given-names>S.L.</given-names></name><name><surname>Chignell</surname><given-names>C.F.</given-names></name></person-group><article-title>Photochemistry and Photocytotoxicity of Alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine</article-title><source>Chem. Res. Toxicol.</source><year>2001</year><volume>14</volume><fpage>1529</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1021/tx0155247</pub-id><pub-id pub-id-type="pmid">11712911</pub-id></element-citation></ref><ref id="B82-molecules-25-04102"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flors</surname><given-names>C.</given-names></name><name><surname>Prat</surname><given-names>C.</given-names></name><name><surname>Suau</surname><given-names>R.</given-names></name><name><surname>Najera</surname><given-names>F.</given-names></name><name><surname>Nonell</surname><given-names>S.</given-names></name></person-group><article-title>Photochemistry of Phytoalexins Containing Phenalenone-like Chromophores: Photophysics and Singlet Oxygen Photosensitizing Properties of the Plant Oxoaporphine Alkaloid Oxoglaucine</article-title><source>Photochem. Photobiol.</source><year>2005</year><volume>81</volume><fpage>120</fpage><pub-id pub-id-type="doi">10.1562/2004-07-23-RA-243.1</pub-id><pub-id pub-id-type="pmid">15493958</pub-id></element-citation></ref><ref id="B83-molecules-25-04102"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>A.H.</given-names></name></person-group><article-title>Photophysics and photochemistry of pterins in aqueous solution</article-title><source>Acc. Chem. Res.</source><year>2006</year><volume>39</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1021/ar050151c</pub-id><?supplied-pmid 16784217?><pub-id pub-id-type="pmid">16784217</pub-id></element-citation></ref><ref id="B84-molecules-25-04102"><label>84.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Phillipson</surname><given-names>J.D.</given-names></name><name><surname>Roberts</surname><given-names>M.F.</given-names></name><name><surname>Zenk</surname><given-names>M.H.</given-names></name></person-group><source>The Chemistry and Biology of Isoquinoline Alkaloids</source><publisher-name>Springer Science &#x00026; Business Media</publisher-name><publisher-loc>Berlin, Germany</publisher-loc><year>2012</year></element-citation></ref><ref id="B85-molecules-25-04102"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignoni</surname><given-names>M.</given-names></name><name><surname>Erra-Balsells</surname><given-names>R.</given-names></name><name><surname>Epe</surname><given-names>B.</given-names></name><name><surname>Cabrerizo</surname><given-names>F.M.</given-names></name></person-group><article-title>Intra- and extra-cellular DNA damage by harmine and 9-methyl-harmine</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2014</year><volume>132</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2014.01.020</pub-id><?supplied-pmid 24602814?><pub-id pub-id-type="pmid">24602814</pub-id></element-citation></ref><ref id="B86-molecules-25-04102"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>L.O.</given-names></name><name><surname>Roman</surname><given-names>E.A.</given-names></name><name><surname>Thomas</surname><given-names>A.H.</given-names></name><name><surname>D&#x000e1;ntola</surname><given-names>M.L.</given-names></name></person-group><article-title>Photooxidation of Tryptophan and Tyrosine Residues in Human Serum Albumin Sensitized by Pterin: A Model for Globular Protein Photodamage in Skin</article-title><source>Biochemistry</source><year>2016</year><volume>55</volume><fpage>4777</fpage><lpage>4786</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.6b00420</pub-id><?supplied-pmid 27500308?><pub-id pub-id-type="pmid">27500308</pub-id></element-citation></ref><ref id="B87-molecules-25-04102"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ya&#x000f1;uk</surname><given-names>J.G.</given-names></name><name><surname>Denofrio</surname><given-names>M.P.</given-names></name><name><surname>Rasse-Suriani</surname><given-names>F.A.O.</given-names></name><name><surname>Villarruel</surname><given-names>F.D.</given-names></name><name><surname>Fassetta</surname><given-names>F.</given-names></name><name><surname>Einschlag</surname><given-names>F.S.G.</given-names></name><name><surname>Erra-Balsells</surname><given-names>R.</given-names></name><name><surname>Epe</surname><given-names>B.</given-names></name><name><surname>Cabrerizo</surname><given-names>F.M.</given-names></name></person-group><article-title>DNA damage photo-induced by chloroharmine isomers: Hydrolysis versus oxidation of nucleobases</article-title><source>Org. Biomol. Chem.</source><year>2018</year><volume>16</volume><fpage>2170</fpage><lpage>2184</lpage><pub-id pub-id-type="doi">10.1039/C8OB00162F</pub-id><pub-id pub-id-type="pmid">29528081</pub-id></element-citation></ref><ref id="B88-molecules-25-04102"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daub</surname><given-names>M.E.</given-names></name><name><surname>Herrero</surname><given-names>S.</given-names></name><name><surname>Chung</surname><given-names>K.-R.</given-names></name></person-group><article-title>Photoactivated perylenequinone toxins in fungal pathogenesis of plants</article-title><source>FEMS Microbiol. Lett.</source><year>2005</year><volume>252</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/j.femsle.2005.08.033</pub-id><pub-id pub-id-type="pmid">16165316</pub-id></element-citation></ref><ref id="B89-molecules-25-04102"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname><given-names>S.C.N.</given-names></name><name><surname>Comini</surname><given-names>L.R.</given-names></name><name><surname>Sarmiento</surname><given-names>M.</given-names></name><name><surname>Becerra</surname><given-names>C.</given-names></name><name><surname>Albesa</surname><given-names>I.</given-names></name><name><surname>Arg&#x000fc;ello</surname><given-names>G.A.</given-names></name><name><surname>Cabrera</surname><given-names>J.L.</given-names></name></person-group><article-title>Natural anthraquinones probed as Type I and Type II photosensitizers: Singlet oxygen and superoxide anion production</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2005</year><volume>78</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2004.09.009</pub-id></element-citation></ref><ref id="B90-molecules-25-04102"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comini</surname><given-names>L.R.</given-names></name><name><surname>Montoya</surname><given-names>S.C.N.</given-names></name><name><surname>Sarmiento</surname><given-names>M.</given-names></name><name><surname>Cabrera</surname><given-names>J.L.</given-names></name><name><surname>Arg&#x000fc;ello</surname><given-names>G.A.</given-names></name></person-group><article-title>Characterizing some photophysical, photochemical and photobiological properties of photosensitizing anthraquinones</article-title><source>J. Photochem. Photobiol. A Chem.</source><year>2007</year><volume>188</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochem.2006.12.011</pub-id></element-citation></ref><ref id="B91-molecules-25-04102"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastrangelopoulou</surname><given-names>M.</given-names></name><name><surname>Grigalavicius</surname><given-names>M.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name><name><surname>M&#x000e9;nard</surname><given-names>M.</given-names></name><name><surname>Theodossiou</surname><given-names>T.A.</given-names></name></person-group><article-title>Cytotoxic and Photocytotoxic Effects of Cercosporin on Human Tumor Cell Lines</article-title><source>Photochem. Photobiol.</source><year>2018</year><volume>95</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1111/php.12997</pub-id><pub-id pub-id-type="pmid">30107033</pub-id></element-citation></ref><ref id="B92-molecules-25-04102"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panno</surname><given-names>M.L.</given-names></name><name><surname>Giordano</surname><given-names>F.</given-names></name><name><surname>Palma</surname><given-names>M.G.</given-names></name><name><surname>Bartella</surname><given-names>V.</given-names></name><name><surname>Rago</surname><given-names>V.</given-names></name><name><surname>Maggiolini</surname><given-names>M.</given-names></name><name><surname>Sisci</surname><given-names>D.</given-names></name><name><surname>Lanzino</surname><given-names>M.</given-names></name><name><surname>De Amicis</surname><given-names>F.</given-names></name><name><surname>Ando</surname><given-names>S.</given-names></name></person-group><article-title>Evidence that bergapten, independently of its photoactivation, enhances p53 gene expression and induces apoptosis in human breast cancer cells</article-title><source>Curr. Cancer Drug Targets</source><year>2009</year><volume>9</volume><fpage>469</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.2174/156800909788486786</pub-id><pub-id pub-id-type="pmid">19519316</pub-id></element-citation></ref><ref id="B93-molecules-25-04102"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panno</surname><given-names>M.L.</given-names></name><name><surname>Giordano</surname><given-names>F.</given-names></name><name><surname>Rizza</surname><given-names>P.</given-names></name><name><surname>Pellegrino</surname><given-names>M.</given-names></name><name><surname>Zito</surname><given-names>D.</given-names></name><name><surname>Giordano</surname><given-names>C.</given-names></name><name><surname>Mauro</surname><given-names>L.</given-names></name><name><surname>Catalano</surname><given-names>S.</given-names></name><name><surname>Aquila</surname><given-names>S.</given-names></name><name><surname>Sisci</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination</article-title><source>Breast Cancer Res. Treat.</source><year>2012</year><volume>136</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1007/s10549-012-2282-3</pub-id><pub-id pub-id-type="pmid">23053665</pub-id></element-citation></ref><ref id="B94-molecules-25-04102"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.-M.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Kim</surname><given-names>C.</given-names></name><name><surname>Baek</surname><given-names>S.H.</given-names></name><name><surname>Nam</surname><given-names>D.</given-names></name><name><surname>Chung</surname><given-names>W.-S.</given-names></name><name><surname>Shim</surname><given-names>B.S.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>S.-H.</given-names></name></person-group><article-title>Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells</article-title><source>Cancer Lett.</source><year>2014</year><volume>354</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2014.08.002</pub-id><?supplied-pmid 25130169?><pub-id pub-id-type="pmid">25130169</pub-id></element-citation></ref><ref id="B95-molecules-25-04102"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.-M.</given-names></name><name><surname>Lee</surname><given-names>E.-J.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Yang</surname><given-names>W.M.</given-names></name><name><surname>Nam</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>S.-G.</given-names></name><name><surname>Um</surname><given-names>J.-Y.</given-names></name><name><surname>Shim</surname><given-names>B.S.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name></person-group><article-title>Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-&#x003ba;B signalling pathway in human chronic myelogenous leukaemia</article-title><source>Pharm. Boil.</source><year>2016</year><volume>54</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3109/13880209.2016.1141221</pub-id><?supplied-pmid 26911804?><pub-id pub-id-type="pmid">26911804</pub-id></element-citation></ref><ref id="B96-molecules-25-04102"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Z.-C.</given-names></name><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>H.-F.</given-names></name><name><surname>Zhang</surname><given-names>H.-M.</given-names></name><name><surname>Wang</surname><given-names>Z.-H.</given-names></name><name><surname>Zhang</surname><given-names>Z.-T.</given-names></name></person-group><article-title>Antitumor and apoptotic effects of bergaptol are mediated via mitochondrial death pathway and cell cycle arrest in human breast carcinoma cells</article-title><source>Bangladesh J. Pharmacol.</source><year>2016</year><volume>11</volume><fpage>489</fpage><pub-id pub-id-type="doi">10.3329/bjp.v11i2.24644</pub-id></element-citation></ref><ref id="B97-molecules-25-04102"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagatani</surname><given-names>T.</given-names></name><name><surname>Matsuzaki</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Baba</surname><given-names>N.</given-names></name><name><surname>Ichiyama</surname><given-names>S.</given-names></name><name><surname>Miyamoto</surname><given-names>H.</given-names></name><name><surname>Nakajima</surname><given-names>H.</given-names></name></person-group><article-title>Treatment of cutaneous T-cell lymphoma (CTCL) by extracorporeal photochemotherapy</article-title><source>J. Dermatol. Sci.</source><year>1990</year><volume>1</volume><fpage>226</fpage><pub-id pub-id-type="doi">10.1016/0923-1811(90)90169-E</pub-id></element-citation></ref><ref id="B98-molecules-25-04102"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethea</surname><given-names>D.</given-names></name><name><surname>Fullmer</surname><given-names>B.</given-names></name><name><surname>Syed</surname><given-names>S.</given-names></name><name><surname>Seltzer</surname><given-names>G.</given-names></name><name><surname>Tiano</surname><given-names>J.</given-names></name><name><surname>Rischko</surname><given-names>C.</given-names></name><name><surname>Gillespie</surname><given-names>L.</given-names></name><name><surname>Brown</surname><given-names>D.</given-names></name><name><surname>Gasparro</surname><given-names>F.P.</given-names></name></person-group><article-title>Psoralen photobiology and photochemotherapy: 50 years of science and medicine</article-title><source>J. Dermatol. Sci.</source><year>1999</year><volume>19</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/S0923-1811(98)00064-4</pub-id><pub-id pub-id-type="pmid">10098699</pub-id></element-citation></ref><ref id="B99-molecules-25-04102"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>K.E.</given-names></name></person-group><article-title>PUVA, Psoralens and Skin Cancer</article-title><source>Skin Cancer UV Radiat.</source><year>1997</year><fpage>416</fpage><lpage>424</lpage></element-citation></ref><ref id="B100-molecules-25-04102"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Domyati</surname><given-names>M.</given-names></name><name><surname>Moftah</surname><given-names>N.H.</given-names></name><name><surname>Nasif</surname><given-names>G.A.</given-names></name><name><surname>Abdel-Wahab</surname><given-names>H.M.</given-names></name><name><surname>Barakat</surname><given-names>M.T.</given-names></name><name><surname>Abdel-Aziz</surname><given-names>R.T.</given-names></name></person-group><article-title>Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis</article-title><source>Photodermatol. Photoimmunol. Photomed.</source><year>2013</year><volume>29</volume><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/phpp.12012</pub-id><pub-id pub-id-type="pmid">23281693</pub-id></element-citation></ref><ref id="B101-molecules-25-04102"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtick</surname><given-names>U.</given-names></name><name><surname>Wang</surname><given-names>X.N.</given-names></name><name><surname>Marshall</surname><given-names>S.R.</given-names></name><name><surname>Von Bergwelt-Baildon</surname><given-names>M.</given-names></name><name><surname>Scheid</surname><given-names>C.</given-names></name><name><surname>Dickinson</surname><given-names>A.M.</given-names></name></person-group><article-title>In Vitro PUVA Treatment Preferentially Induces Apoptosis in Alloactivated T Cells</article-title><source>Transplantation</source><year>2012</year><volume>94</volume><fpage>e31</fpage><lpage>e34</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e31825f4454</pub-id><pub-id pub-id-type="pmid">22955171</pub-id></element-citation></ref><ref id="B102-molecules-25-04102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>I.M.</given-names></name><name><surname>Chimenti</surname><given-names>S.</given-names></name><name><surname>Gasparro</surname><given-names>F.P.</given-names></name></person-group><article-title>Psoralen-protein photochemistry&#x02014;A forgotten field</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>1995</year><volume>27</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/1011-1344(94)07101-S</pub-id></element-citation></ref><ref id="B103-molecules-25-04102"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Aelst</surname><given-names>B.</given-names></name><name><surname>Devloo</surname><given-names>R.</given-names></name><name><surname>Zachee</surname><given-names>P.</given-names></name><name><surname>T&#x02019;Kindt</surname><given-names>R.</given-names></name><name><surname>Sandra</surname><given-names>K.</given-names></name><name><surname>Vandekerckhove</surname><given-names>P.</given-names></name><name><surname>Compernolle</surname><given-names>V.</given-names></name><name><surname>Feys</surname><given-names>H.B.</given-names></name></person-group><article-title>Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing</article-title><source>J. Boil. Chem.</source><year>2016</year><volume>291</volume><fpage>24364</fpage><lpage>24376</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.735126</pub-id></element-citation></ref><ref id="B104-molecules-25-04102"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>W.</given-names></name><name><surname>Gooden</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Soderblom</surname><given-names>E.J.</given-names></name><name><surname>Toone</surname><given-names>E.J.</given-names></name><name><surname>Beyer</surname><given-names>W.F.</given-names></name><name><surname>Walder</surname><given-names>H.</given-names></name><name><surname>Spector</surname><given-names>N.</given-names></name></person-group><article-title>Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e88983</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088983</pub-id><?supplied-pmid 24551203?><pub-id pub-id-type="pmid">24551203</pub-id></element-citation></ref><ref id="B105-molecules-25-04102"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>G.</given-names></name><name><surname>Col&#x000f3;n</surname><given-names>K.L.</given-names></name><name><surname>Fuller</surname><given-names>A.</given-names></name><name><surname>Sainuddin</surname><given-names>T.</given-names></name><name><surname>Bradner</surname><given-names>E.</given-names></name><name><surname>McCain</surname><given-names>J.</given-names></name><name><surname>Monro</surname><given-names>S.M.A.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Hetu</surname><given-names>M.W.</given-names></name><name><surname>Cameron</surname><given-names>C.G.</given-names></name><etal/></person-group><article-title>Cyclometalated Ruthenium(II) Complexes Derived from &#x003b1;-Oligothiophenes as Highly Selective Cytotoxic or Photocytotoxic Agents</article-title><source>Inorg. Chem.</source><year>2018</year><volume>57</volume><fpage>7694</fpage><lpage>7712</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.8b00689</pub-id><?supplied-pmid 29927243?><pub-id pub-id-type="pmid">29927243</pub-id></element-citation></ref><ref id="B106-molecules-25-04102"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Jin</surname><given-names>W.-R.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Qu</surname><given-names>H.-B.</given-names></name></person-group><article-title>Two novel thiophenes from Echinops grijissi Hance</article-title><source>J. Asian Nat. Prod. Res.</source><year>2008</year><volume>10</volume><fpage>977</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1080/10286020802240467</pub-id><?supplied-pmid 19003618?><pub-id pub-id-type="pmid">19003618</pub-id></element-citation></ref><ref id="B107-molecules-25-04102"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galushko</surname><given-names>S.</given-names></name><name><surname>Shishkina</surname><given-names>I.</given-names></name><name><surname>Alekseeva</surname><given-names>I.</given-names></name></person-group><article-title>Relationship between retention parameters in reversed-phase high-performance liquid chromatography and antitumour activity of some pyrimidine bases and nucleosides</article-title><source>J. Chromatogr. A</source><year>1991</year><volume>547</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0021-9673(01)88639-8</pub-id></element-citation></ref><ref id="B108-molecules-25-04102"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.D.</given-names></name><name><surname>Johnson</surname><given-names>S.</given-names></name><name><surname>Powell</surname><given-names>D.</given-names></name><name><surname>McGinnis</surname><given-names>J.P.</given-names></name><name><surname>Miranda</surname><given-names>M.</given-names></name><name><surname>Rabindran</surname><given-names>S.K.</given-names></name></person-group><article-title>Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2005</year><volume>15</volume><fpage>3763</fpage><lpage>3766</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2005.05.127</pub-id><pub-id pub-id-type="pmid">16005212</pub-id></element-citation></ref><ref id="B109-molecules-25-04102"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alagarsamy</surname><given-names>V.</given-names></name><name><surname>Meena</surname><given-names>S.</given-names></name><name><surname>Ramseshu</surname><given-names>K.</given-names></name><name><surname>Solomon</surname><given-names>V.</given-names></name><name><surname>Thirumurugan</surname><given-names>K.</given-names></name><name><surname>Dhanabal</surname><given-names>K.</given-names></name><name><surname>Murugan</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis, analgesic, anti-inflammatory, ulcerogenic index and antibacterial activities of novel 2-methylthio-3-substituted-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-4(3H)-ones</article-title><source>Eur. J. Med. Chem.</source><year>2006</year><volume>41</volume><fpage>1293</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2006.06.005</pub-id><pub-id pub-id-type="pmid">16928409</pub-id></element-citation></ref><ref id="B110-molecules-25-04102"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starcevic</surname><given-names>K.</given-names></name><name><surname>Kralj</surname><given-names>M.</given-names></name><name><surname>Piantanida</surname><given-names>I.</given-names></name><name><surname>&#x00160;uman</surname><given-names>L.</given-names></name><name><surname>Pavelic</surname><given-names>K.</given-names></name><name><surname>Karminski-Zamola</surname><given-names>G.</given-names></name></person-group><article-title>Synthesis, photochemical synthesis, DNA binding and antitumor evaluation of novel cyano- and amidino-substituted derivatives of naphtho-furans, naphtho-thiophenes, thieno-benzofurans, benzo-dithiophenes and their acyclic precursors</article-title><source>Eur. J. Med. Chem.</source><year>2006</year><volume>41</volume><fpage>925</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2006.03.012</pub-id><pub-id pub-id-type="pmid">16650510</pub-id></element-citation></ref><ref id="B111-molecules-25-04102"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>M.A.</given-names></name><name><surname>Romero</surname><given-names>M.A.</given-names></name><name><surname>Navarro</surname><given-names>J.A.</given-names></name></person-group><article-title>Cyclic assemblies formed by metal ions, pyrimidines and isogeometrical heterocycles: DNA binding properties and antitumour activity</article-title><source>Inorg. Chim. Acta</source><year>2009</year><volume>362</volume><fpage>1027</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1016/j.ica.2008.04.007</pub-id></element-citation></ref><ref id="B112-molecules-25-04102"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prachayasittikul</surname><given-names>S.</given-names></name><name><surname>Worachartcheewan</surname><given-names>A.</given-names></name><name><surname>Nantasenamat</surname><given-names>C.</given-names></name><name><surname>Chinworrungsee</surname><given-names>M.</given-names></name><name><surname>Sornsongkhram</surname><given-names>N.</given-names></name><name><surname>Ruchirawat</surname><given-names>S.</given-names></name><name><surname>Prachayasittikul</surname><given-names>V.</given-names></name></person-group><article-title>Synthesis and structure&#x02013;activity relationship of 2-thiopyrimidine-4-one analogs as antimicrobial and anticancer agents</article-title><source>Eur. J. Med. Chem.</source><year>2011</year><volume>46</volume><fpage>738</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2010.12.009</pub-id><pub-id pub-id-type="pmid">21216051</pub-id></element-citation></ref><ref id="B113-molecules-25-04102"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>Q.</given-names></name><name><surname>Hong</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Qu</surname><given-names>H.</given-names></name></person-group><article-title>Cytotoxic properties of thiophenes from Echinops grijissi Hance</article-title><source>Phytomedicine</source><year>2008</year><volume>15</volume><fpage>768</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2007.10.007</pub-id><pub-id pub-id-type="pmid">18068965</pub-id></element-citation></ref><ref id="B114-molecules-25-04102"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karunagaran</surname><given-names>D.</given-names></name><name><surname>Rashmi</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>T.R.S.</given-names></name></person-group><article-title>Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy</article-title><source>Curr. Cancer Drug Targets</source><year>2005</year><volume>5</volume><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.2174/1568009053202081</pub-id><?supplied-pmid 15810876?><pub-id pub-id-type="pmid">15810876</pub-id></element-citation></ref><ref id="B115-molecules-25-04102"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name><name><surname>De Vries</surname><given-names>H.</given-names></name><name><surname>Karlsen</surname><given-names>J.</given-names></name><name><surname>Van Henegouwen</surname><given-names>G.B.</given-names></name></person-group><article-title>Studies on Curcumin and Curcuminoids IX: Investigation of the Photobiological Activity of Curcumin Using Bacterial Indicator Systems</article-title><source>J. Pharm. Sci.</source><year>1987</year><volume>76</volume><fpage>371</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1002/jps.2600760506</pub-id><pub-id pub-id-type="pmid">3309256</pub-id></element-citation></ref><ref id="B116-molecules-25-04102"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>T.A.</given-names></name><name><surname>McGowan</surname><given-names>W.M.</given-names></name><name><surname>Shand</surname><given-names>M.A.</given-names></name><name><surname>Srinivasan</surname><given-names>V.S.</given-names></name></person-group><article-title>Photokilling of bacteria by the natural dye curcumin</article-title><source>Arch. Microbiol.</source><year>1989</year><volume>151</volume><fpage>183</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1007/BF00414437</pub-id><?supplied-pmid 2655550?><pub-id pub-id-type="pmid">2655550</pub-id></element-citation></ref><ref id="B117-molecules-25-04102"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haukvik</surname><given-names>T.</given-names></name><name><surname>Bruzell</surname><given-names>E.</given-names></name><name><surname>Kristensen</surname><given-names>S.</given-names></name><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name></person-group><article-title>Photokilling of bacteria by curcumin in selected polyethylene glycol 400 (PEG 400) preparations. Studies on curcumin and curcuminoids, XLI</article-title><source>Die Pharm.</source><year>2010</year><volume>65</volume><fpage>600</fpage><lpage>606</lpage></element-citation></ref><ref id="B118-molecules-25-04102"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardo</surname><given-names>L.</given-names></name><name><surname>Andreoni</surname><given-names>A.</given-names></name><name><surname>M&#x000e1;sson</surname><given-names>M.</given-names></name><name><surname>Haukvik</surname><given-names>T.</given-names></name><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name></person-group><article-title>Studies on Curcumin and Curcuminoids. XXXIX. Photophysical Properties of Bisdemethoxycurcumin</article-title><source>J. Fluoresc.</source><year>2010</year><volume>21</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1007/s10895-010-0750-x</pub-id><?supplied-pmid 20953820?><pub-id pub-id-type="pmid">20953820</pub-id></element-citation></ref><ref id="B119-molecules-25-04102"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruzell</surname><given-names>E.M.</given-names></name><name><surname>Morisbak</surname><given-names>E.</given-names></name><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name></person-group><article-title>Studies on curcumin and curcuminoids. XXIX. Photoinduced cytotoxicity of curcumin in selected aqueous preparations</article-title><source>Photochem. Photobiol. Sci.</source><year>2005</year><volume>4</volume><fpage>523</fpage><pub-id pub-id-type="doi">10.1039/b503397g</pub-id><pub-id pub-id-type="pmid">15986060</pub-id></element-citation></ref><ref id="B120-molecules-25-04102"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardo</surname><given-names>L.</given-names></name><name><surname>Andreoni</surname><given-names>A.</given-names></name><name><surname>Bondani</surname><given-names>M.</given-names></name><name><surname>M&#x000e1;sson</surname><given-names>M.</given-names></name><name><surname>Haukvik</surname><given-names>T.</given-names></name><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name></person-group><article-title>Studies on Curcumin and Curcuminoids. XLVI. Photophysical Properties of Dimethoxycurcumin and Bis-dehydroxycurcumin</article-title><source>J. Fluoresc.</source><year>2011</year><volume>22</volume><fpage>597</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1007/s10895-011-0995-z</pub-id><pub-id pub-id-type="pmid">22037833</pub-id></element-citation></ref><ref id="B121-molecules-25-04102"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardo</surname><given-names>L.</given-names></name><name><surname>Andreoni</surname><given-names>A.</given-names></name><name><surname>Bondani</surname><given-names>M.</given-names></name><name><surname>M&#x000e1;sson</surname><given-names>M.</given-names></name><name><surname>T&#x000f8;nnesen</surname><given-names>H.H.</given-names></name></person-group><article-title>Studies on curcumin and curcuminoids. XXXIV. Photophysical properties of a symmetrical, non-substituted curcumin analogue</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2009</year><volume>97</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2009.08.004</pub-id></element-citation></ref><ref id="B122-molecules-25-04102"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>N.C.</given-names></name><name><surname>Fontana</surname><given-names>C.R.</given-names></name><name><surname>Gerbi</surname><given-names>M.E.M.</given-names></name><name><surname>Bagnato</surname><given-names>V.S.</given-names></name></person-group><article-title>Overall-Mouth Disinfection by Photodynamic Therapy Using Curcumin</article-title><source>Photomed. Laser Surg.</source><year>2012</year><volume>30</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1089/pho.2011.3053</pub-id><pub-id pub-id-type="pmid">22224655</pub-id></element-citation></ref><ref id="B123-molecules-25-04102"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rego-Filho</surname><given-names>F.D.A.</given-names></name><name><surname>De Araujo</surname><given-names>M.T.</given-names></name><name><surname>De Oliveira</surname><given-names>K.T.</given-names></name><name><surname>Bagnato</surname><given-names>V.S.</given-names></name></person-group><article-title>Validation of Photodynamic Action via Photobleaching of a New Curcumin-Based Composite with Enhanced Water Solubility</article-title><source>J. Fluoresc.</source><year>2014</year><volume>24</volume><fpage>1407</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1007/s10895-014-1422-z</pub-id><pub-id pub-id-type="pmid">24989150</pub-id></element-citation></ref><ref id="B124-molecules-25-04102"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreedhar</surname><given-names>A.</given-names></name><name><surname>Sarkar</surname><given-names>I.</given-names></name><name><surname>Rajan</surname><given-names>P.</given-names></name><name><surname>Pai</surname><given-names>J.</given-names></name><name><surname>Malagi</surname><given-names>S.</given-names></name><name><surname>Kamath</surname><given-names>V.</given-names></name><name><surname>Barmappa</surname><given-names>R.</given-names></name></person-group><article-title>Comparative evaluation of the efficacy of curcumin gel with and without photo activation as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A split mouth clinical and microbiological study</article-title><source>J. Nat. Sci. Boil. Med.</source><year>2015</year><volume>6</volume><fpage>102</fpage><lpage>S109</lpage><pub-id pub-id-type="doi">10.4103/0976-9668.166100</pub-id><?supplied-pmid 26604595?><pub-id pub-id-type="pmid">26604595</pub-id></element-citation></ref><ref id="B125-molecules-25-04102"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacRobert</surname><given-names>A.J.</given-names></name><name><surname>Komerik</surname><given-names>N.</given-names></name></person-group><article-title>Photodynamic Therapy as an Alternative Antimicrobial Modality for Oral Infections</article-title><source>J. Environ. Pathol. Toxicol. Oncol.</source><year>2006</year><volume>25</volume><fpage>487</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1615/JEnvironPatholToxicolOncol.v25.i1-2.310</pub-id><?supplied-pmid 16566737?><pub-id pub-id-type="pmid">16566737</pub-id></element-citation></ref><ref id="B126-molecules-25-04102"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarsini</surname><given-names>K.I.</given-names></name></person-group><article-title>Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells</article-title><source>J. Photochem. Photobiol. C Photochem. Rev.</source><year>2009</year><volume>10</volume><fpage>81</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochemrev.2009.05.001</pub-id></element-citation></ref><ref id="B127-molecules-25-04102"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maheshwari</surname><given-names>R.K.</given-names></name><name><surname>Singh</surname><given-names>A.K.</given-names></name><name><surname>Gaddipati</surname><given-names>J.</given-names></name><name><surname>Srimal</surname><given-names>R.C.</given-names></name></person-group><article-title>Multiple biological activities of curcumin: A short review</article-title><source>Life Sci.</source><year>2006</year><volume>78</volume><fpage>2081</fpage><lpage>2087</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.12.007</pub-id><?supplied-pmid 16413584?><pub-id pub-id-type="pmid">16413584</pub-id></element-citation></ref><ref id="B128-molecules-25-04102"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yance</surname><given-names>D.R.</given-names></name><name><surname>Sagar</surname><given-names>S.M.</given-names></name></person-group><article-title>Targeting Angiogenesis with Integrative Cancer Therapies</article-title><source>Integr. Cancer Ther.</source><year>2006</year><volume>5</volume><fpage>9</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1177/1534735405285562</pub-id><?supplied-pmid 16484711?><pub-id pub-id-type="pmid">16484711</pub-id></element-citation></ref><ref id="B129-molecules-25-04102"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvioli</surname><given-names>S.</given-names></name><name><surname>Sikora</surname><given-names>E.</given-names></name><name><surname>Cooper</surname><given-names>E.L.</given-names></name><name><surname>Franceschi</surname><given-names>C.</given-names></name></person-group><article-title>Curcumin in Cell Death Processes: A Challenge for CAM of Age-Related Pathologies</article-title><source>Evidence-Based Complement Altern. Med.</source><year>2007</year><volume>4</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1093/ecam/nem043</pub-id></element-citation></ref><ref id="B130-molecules-25-04102"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallianou</surname><given-names>N.</given-names></name><name><surname>Evangelopoulos</surname><given-names>A.</given-names></name><name><surname>Schizas</surname><given-names>N.</given-names></name><name><surname>Kazazis</surname><given-names>C.</given-names></name></person-group><article-title>Potential anticancer properties and mechanisms of action of curcumin</article-title><source>Anticancer Res.</source><year>2015</year><volume>35</volume><fpage>645</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">25667441</pub-id></element-citation></ref><ref id="B131-molecules-25-04102"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.-Y.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Yum</surname><given-names>H.-W.</given-names></name><name><surname>Lee</surname><given-names>H.-J.</given-names></name><name><surname>Kundu</surname><given-names>J.K.</given-names></name><name><surname>Na</surname><given-names>H.-K.</given-names></name><name><surname>Surh</surname><given-names>Y.-J.</given-names></name></person-group><article-title>Curcumin Inhibits STAT3 Signaling in the Colon of Dextran Sulfate Sodium-treated Mice</article-title><source>J. Cancer Prev.</source><year>2013</year><volume>18</volume><fpage>186</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.15430/JCP.2013.18.2.186</pub-id><pub-id pub-id-type="pmid">25337545</pub-id></element-citation></ref><ref id="B132-molecules-25-04102"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dovigo</surname><given-names>L.N.</given-names></name><name><surname>Pavarina</surname><given-names>A.C.</given-names></name><name><surname>Carmello</surname><given-names>J.C.</given-names></name><name><surname>Machado</surname><given-names>A.L.</given-names></name><name><surname>Brunetti</surname><given-names>I.L.</given-names></name><name><surname>Bagnato</surname><given-names>V.S.</given-names></name></person-group><article-title>Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin</article-title><source>Lasers Surg. Med.</source><year>2011</year><volume>43</volume><fpage>927</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1002/lsm.21110</pub-id><pub-id pub-id-type="pmid">22006736</pub-id></element-citation></ref><ref id="B133-molecules-25-04102"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernd</surname><given-names>A.</given-names></name></person-group><article-title>Visible light and/or UVA offer a strong amplification of the anti-tumor effect of curcumin</article-title><source>Phytochem. Rev.</source><year>2013</year><volume>13</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1007/s11101-013-9296-2</pub-id><pub-id pub-id-type="pmid">24578676</pub-id></element-citation></ref><ref id="B134-molecules-25-04102"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>W.-H.</given-names></name><name><surname>Wu</surname><given-names>H.-J.</given-names></name></person-group><article-title>Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells</article-title><source>J. Cell. Biochem.</source><year>2004</year><volume>92</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1002/jcb.20059</pub-id><?supplied-pmid 15095415?><pub-id pub-id-type="pmid">15095415</pub-id></element-citation></ref><ref id="B135-molecules-25-04102"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>N.C.</given-names></name><name><surname>Fontana</surname><given-names>C.R.</given-names></name><name><surname>Bagnato</surname><given-names>V.S.</given-names></name><name><surname>Gerbi</surname><given-names>M.E.M.</given-names></name></person-group><article-title>Photodynamic Effects of Curcumin Against Cariogenic Pathogens</article-title><source>Photomed. Laser Surg.</source><year>2012</year><volume>30</volume><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1089/pho.2011.3195</pub-id><pub-id pub-id-type="pmid">22693952</pub-id></element-citation></ref><ref id="B136-molecules-25-04102"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benyhe</surname><given-names>S.</given-names></name></person-group><article-title>Morphine: New aspects in the study of an ancient compound</article-title><source>Life Sci.</source><year>1994</year><volume>55</volume><fpage>969</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(94)00631-8</pub-id><pub-id pub-id-type="pmid">8084213</pub-id></element-citation></ref><ref id="B137-molecules-25-04102"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Tong</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name></person-group><article-title>BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles</article-title><source>Cancer Boil. Ther.</source><year>2007</year><volume>6</volume><fpage>787</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.4161/cbt.6.5.4006</pub-id><?supplied-pmid 17387272?><pub-id pub-id-type="pmid">17387272</pub-id></element-citation></ref><ref id="B138-molecules-25-04102"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Miao</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Chimmitecan, a Novel 9-Substituted Camptothecin, with Improved Anticancer Pharmacologic Profiles In vitro and In vivo</article-title><source>Clin. Cancer Res.</source><year>2007</year><volume>13</volume><fpage>1298</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-1277</pub-id><?supplied-pmid 17287296?><pub-id pub-id-type="pmid">17287296</pub-id></element-citation></ref><ref id="B139-molecules-25-04102"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Xun</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs</article-title><source>Anti-Cancer Drugs</source><year>2009</year><volume>20</volume><fpage>757</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1097/CAD.0b013e328330d95b</pub-id><pub-id pub-id-type="pmid">19704371</pub-id></element-citation></ref><ref id="B140-molecules-25-04102"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eom</surname><given-names>K.S.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>So</surname><given-names>H.-S.</given-names></name><name><surname>Park</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>T.Y.</given-names></name></person-group><article-title>Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction</article-title><source>Boil. Pharm. Bull.</source><year>2010</year><volume>33</volume><fpage>1644</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1248/bpb.33.1644</pub-id></element-citation></ref><ref id="B141-molecules-25-04102"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diogo</surname><given-names>C.V.</given-names></name><name><surname>Machado</surname><given-names>N.G.</given-names></name><name><surname>Barbosa</surname><given-names>I.A.</given-names></name><name><surname>Serafim</surname><given-names>T.L.</given-names></name><name><surname>Burgeiro</surname><given-names>A.</given-names></name><name><surname>Oliveira</surname><given-names>P.J.</given-names></name></person-group><article-title>Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?</article-title><source>Curr. Drug Targets</source><year>2011</year><volume>12</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.2174/138945011795528930</pub-id><pub-id pub-id-type="pmid">21269266</pub-id></element-citation></ref><ref id="B142-molecules-25-04102"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>J.-J.</given-names></name><name><surname>Huang</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Gong</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Dang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Anti-cancer natural products isolated from chinese medicinal herbs</article-title><source>Chin. Med.</source><year>2011</year><volume>6</volume><fpage>27</fpage><pub-id pub-id-type="doi">10.1186/1749-8546-6-27</pub-id><pub-id pub-id-type="pmid">21777476</pub-id></element-citation></ref><ref id="B143-molecules-25-04102"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgeiro</surname><given-names>A.A.C.</given-names></name><name><surname>Gajate</surname><given-names>C.</given-names></name><name><surname>Dakir</surname><given-names>E.H.</given-names></name><name><surname>Villa-Pulgarin</surname><given-names>J.A.</given-names></name><name><surname>Oliveira</surname><given-names>P.J.</given-names></name><name><surname>Mollinedo</surname><given-names>F.</given-names></name></person-group><article-title>Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells</article-title><source>Anti-Cancer Drugs</source><year>2011</year><volume>22</volume><fpage>507</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1097/CAD.0b013e32834438f6</pub-id><pub-id pub-id-type="pmid">21527846</pub-id></element-citation></ref><ref id="B144-molecules-25-04102"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youn</surname><given-names>M.-J.</given-names></name><name><surname>So</surname><given-names>H.-S.</given-names></name><name><surname>Cho</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Sohn</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Chung</surname><given-names>S.-Y.</given-names></name><name><surname>Park</surname><given-names>R.</given-names></name></person-group><article-title>Berberine, a Natural Product, Combined with Cisplatin Enhanced Apoptosis through a Mitochondria/Caspase-Mediated Pathway in HeLa Cells</article-title><source>Boil. Pharm. Bull.</source><year>2008</year><volume>31</volume><fpage>789</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1248/bpb.31.789</pub-id><?supplied-pmid 18451495?><pub-id pub-id-type="pmid">18451495</pub-id></element-citation></ref><ref id="B145-molecules-25-04102"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>J.-M.</given-names></name><name><surname>Hyun</surname><given-names>M.-S.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>W.-Y.</given-names></name><name><surname>Kim</surname><given-names>N.</given-names></name></person-group><article-title>The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells</article-title><source>J. Cell. Biochem.</source><year>2009</year><volume>107</volume><fpage>955</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1002/jcb.22198</pub-id><?supplied-pmid 19492307?><pub-id pub-id-type="pmid">19492307</pub-id></element-citation></ref><ref id="B146-molecules-25-04102"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreazza</surname><given-names>N.L.</given-names></name><name><surname>Vevert-Bizet</surname><given-names>C.</given-names></name><name><surname>Bourg-Heckly</surname><given-names>G.</given-names></name><name><surname>Sureau</surname><given-names>F.</given-names></name><name><surname>Salvador</surname><given-names>M.J.</given-names></name><name><surname>Bonneau</surname><given-names>S.</given-names></name></person-group><article-title>Berberine as a Photosensitizing Agent for Antitumoral Photodynamic Therapy: Insights into its Association to Low Density Lipoproteins</article-title><source>Int. J. Pharm.</source><year>2016</year><volume>510</volume><fpage>240</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.06.009</pub-id><?supplied-pmid 27282536?><pub-id pub-id-type="pmid">27282536</pub-id></element-citation></ref><ref id="B147-molecules-25-04102"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>P.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>S.K.</given-names></name><name><surname>Patro</surname><given-names>B.S.</given-names></name><name><surname>Chattopadhyay</surname><given-names>S.</given-names></name></person-group><article-title>Coralyne, a protoberberine alkaloid, causes robust photosenstization of cancer cells through ATR-p38 MAPK-BAX and JAK2-STAT1-BAX pathways</article-title><source>Chem. Interact.</source><year>2018</year><volume>285</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2018.02.032</pub-id><?supplied-pmid 29486184?><pub-id pub-id-type="pmid">29486184</pub-id></element-citation></ref><ref id="B148-molecules-25-04102"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n</surname><given-names>J.P.</given-names></name><name><surname>Labrador</surname><given-names>V.</given-names></name><name><surname>Freire</surname><given-names>P.F.</given-names></name><name><surname>Molero</surname><given-names>M.L.</given-names></name><name><surname>Hazen</surname><given-names>M.</given-names></name></person-group><article-title>Ultrastructural changes induced in HeLa cells after phototoxic treatment with harmine</article-title><source>J. Appl. Toxicol.</source><year>2004</year><volume>24</volume><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1002/jat.972</pub-id><?supplied-pmid 15211613?><pub-id pub-id-type="pmid">15211613</pub-id></element-citation></ref><ref id="B149-molecules-25-04102"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnason</surname><given-names>J.T.</given-names></name><name><surname>Towers</surname><given-names>G.H.N.</given-names></name><name><surname>Abramowski</surname><given-names>Z.</given-names></name><name><surname>Campos</surname><given-names>F.</given-names></name><name><surname>Champagne</surname><given-names>D.</given-names></name><name><surname>McLachlan</surname><given-names>D.</given-names></name><name><surname>Philog&#x000e8;ne</surname><given-names>B.J.R.</given-names></name></person-group><article-title>Berberine: A naturally occurring phototoxic alkaloid</article-title><source>J. Chem. Ecol.</source><year>1984</year><volume>10</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1007/bf00987648</pub-id><pub-id pub-id-type="pmid">24318233</pub-id></element-citation></ref><ref id="B150-molecules-25-04102"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L.-L.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>R.-R.</given-names></name><name><surname>Sun</surname><given-names>X.-Y.</given-names></name><name><surname>Yao</surname><given-names>S.-D.</given-names></name><name><surname>Wu</surname><given-names>Q.-S.</given-names></name><name><surname>Wang</surname><given-names>S.-L.</given-names></name></person-group><article-title>Characterization of the transient species generated by the photoionization of Berberine: A laser flash photolysis study</article-title><source>Spectrochim. Acta Part A Mol. Biomol. Spectrosc.</source><year>2009</year><volume>73</volume><fpage>955</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2009.05.001</pub-id></element-citation></ref><ref id="B151-molecules-25-04102"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantova</surname><given-names>S.</given-names></name><name><surname>Leta&#x00161;iov&#x000e1;</surname><given-names>S.</given-names></name><name><surname>Brezov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Cipak</surname><given-names>L.</given-names></name><name><surname>L&#x000e1;baj</surname><given-names>J.</given-names></name></person-group><article-title>Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells</article-title><source>J. Photochem. Photobiol. B Boil.</source><year>2006</year><volume>85</volume><fpage>163</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2006.07.001</pub-id></element-citation></ref><ref id="B152-molecules-25-04102"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dave</surname><given-names>H.</given-names></name><name><surname>Ledwani</surname><given-names>L.</given-names></name></person-group><article-title>A review on anthraquinones isolated from Cassia species and their applications</article-title><source>Indian J. Nat. Prod. Resour.</source><year>2012</year><volume>3</volume><fpage>291</fpage><lpage>319</lpage></element-citation></ref><ref id="B153-molecules-25-04102"><label>153.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Seigler</surname><given-names>D.S.</given-names></name></person-group><source>Plant Secondary Metabolism</source><publisher-name>Springer Science &#x00026; Business Media</publisher-name><publisher-loc>Berlin, Germany</publisher-loc><year>1998</year></element-citation></ref><ref id="B154-molecules-25-04102"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guti&#x000e9;rrez</surname><given-names>I.</given-names></name><name><surname>Bertolotti</surname><given-names>S.G.</given-names></name><name><surname>Biasutti</surname><given-names>M.</given-names></name><name><surname>Soltermann</surname><given-names>A.T.</given-names></name><name><surname>Garc&#x000ed;a</surname><given-names>N.A.</given-names></name></person-group><article-title>Quinones and hydroxyquinones as generators and quenchers of singlet molecular oxygen</article-title><source>Can. J. Chem.</source><year>1997</year><volume>75</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1139/v97-048</pub-id></element-citation></ref><ref id="B155-molecules-25-04102"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paw&#x00142;owska</surname><given-names>J.</given-names></name><name><surname>Tarasiuk</surname><given-names>J.</given-names></name><name><surname>Wolf</surname><given-names>C.R.</given-names></name><name><surname>Paine</surname><given-names>M.J.I.</given-names></name><name><surname>Borowski</surname><given-names>E.</given-names></name></person-group><article-title>Differential Ability of Cytostatics From Anthraquinone Group to Generate Free Radicals in Three Enzymatic Systems: NADH Dehydrogenase, NADPH Cytochrome P450 Reductase, and Xanthine Oxidase</article-title><source>Oncol. Res. Featur. Preclin. Clin. Cancer Ther.</source><year>2003</year><volume>13</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.3727/096504003108748294</pub-id><?supplied-pmid 12688675?><pub-id pub-id-type="pmid">12688675</pub-id></element-citation></ref><ref id="B156-molecules-25-04102"><label>156.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A.</given-names></name></person-group><source>Herbal Drugs as Therapeutic Agents</source><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2014</year></element-citation></ref><ref id="B157-molecules-25-04102"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname><given-names>S.C.N.</given-names></name><name><surname>Comini</surname><given-names>L.</given-names></name><name><surname>Vittar</surname><given-names>B.R.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>I.M.</given-names></name><name><surname>Rivarola</surname><given-names>V.A.</given-names></name><name><surname>Cabrera</surname><given-names>J.L.</given-names></name></person-group><article-title>Phototoxic effects of Heterophyllaea pustulata (Rubiaceae)</article-title><source>Toxicon</source><year>2008</year><volume>51</volume><fpage>1409</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.03.011</pub-id><?supplied-pmid 18513778?><pub-id pub-id-type="pmid">18513778</pub-id></element-citation></ref><ref id="B158-molecules-25-04102"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comini</surname><given-names>L.</given-names></name><name><surname>Fernandez</surname><given-names>I.</given-names></name><name><surname>Vittar</surname><given-names>N.R.</given-names></name><name><surname>Montoya</surname><given-names>S.N.</given-names></name><name><surname>Cabrera</surname><given-names>J.L.</given-names></name><name><surname>Rivarola</surname><given-names>V.A.</given-names></name></person-group><article-title>Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f. (Rubiaceae) on MCF-7c3 breast cancer cells</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>1093</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.05.008</pub-id><?supplied-pmid 21665453?><pub-id pub-id-type="pmid">21665453</pub-id></element-citation></ref><ref id="B159-molecules-25-04102"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vittar</surname><given-names>N.B.R.</given-names></name><name><surname>Awruch</surname><given-names>J.</given-names></name><name><surname>Azizuddin</surname><given-names>K.</given-names></name><name><surname>Rivarola</surname><given-names>V.A.</given-names></name></person-group><article-title>Caspase-independent apoptosis, in human MCF-7c3 breast cancer cells, following photodynamic therapy, with a novel water-soluble phthalocyanine</article-title><source>Int. J. Biochem. Cell Boil.</source><year>2010</year><volume>42</volume><fpage>1123</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2010.03.019</pub-id></element-citation></ref><ref id="B160-molecules-25-04102"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirillo</surname><given-names>J.</given-names></name><name><surname>De Simone</surname><given-names>B.C.</given-names></name><name><surname>Russo</surname><given-names>N.</given-names></name></person-group><article-title>Photophysical properties prediction of selenium- and tellurium-substituted thymidine as potential UVA chemotherapeutic agents</article-title><source>Theor. Chem. Accounts</source><year>2015</year><volume>135</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1007/s00214-015-1744-1</pub-id></element-citation></ref><ref id="B161-molecules-25-04102"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzone</surname><given-names>G.</given-names></name><name><surname>Alberto</surname><given-names>M.E.</given-names></name><name><surname>De Simone</surname><given-names>B.C.</given-names></name><name><surname>Marino</surname><given-names>T.</given-names></name><name><surname>Russo</surname><given-names>N.</given-names></name></person-group><article-title>Can Expanded Bacteriochlorins Act as Photosensitizers in Photodynamic Therapy? Good News from Density Functional Theory Computations</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>288</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21030288</pub-id><?supplied-pmid 26938516?><pub-id pub-id-type="pmid">26938516</pub-id></element-citation></ref><ref id="B162-molecules-25-04102"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansoori</surname><given-names>B.</given-names></name><name><surname>Mohammadi</surname><given-names>A.</given-names></name><name><surname>Doustvandi</surname><given-names>M.A.</given-names></name><name><surname>Mohammadnejad</surname><given-names>F.</given-names></name><name><surname>Kamari</surname><given-names>F.</given-names></name><name><surname>Gjerstorff</surname><given-names>M.F.</given-names></name><name><surname>Baradaran</surname><given-names>B.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><article-title>Photodynamic therapy for cancer: Role of natural products</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2019</year><volume>26</volume><fpage>395</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2019.04.033</pub-id><?supplied-pmid 31063860?><pub-id pub-id-type="pmid">31063860</pub-id></element-citation></ref><ref id="B163-molecules-25-04102"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>R.K.</given-names></name><name><surname>Goswami</surname><given-names>L.N.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Gryshuk</surname><given-names>A.</given-names></name><name><surname>Missert</surname><given-names>J.R.</given-names></name><name><surname>Oseroff</surname><given-names>A.</given-names></name><name><surname>Dougherty</surname><given-names>T.J.</given-names></name></person-group><article-title>Nature: A rich source for developing multifunctional agents. tumor-imaging and photodynamic therapy</article-title><source>Lasers Surg. Med.</source><year>2006</year><volume>38</volume><fpage>445</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1002/lsm.20352</pub-id><pub-id pub-id-type="pmid">16788930</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-04102-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The general mechanism of photodynamic therapy.</p></caption><graphic xlink:href="molecules-25-04102-g001"/></fig><fig id="molecules-25-04102-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Phototherapeutic window of natural compounds.</p></caption><graphic xlink:href="molecules-25-04102-g002"/></fig><fig id="molecules-25-04102-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Natural photoactive compounds presented in this review.</p></caption><graphic xlink:href="molecules-25-04102-g003"/></fig><fig id="molecules-25-04102-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Common molecular targets of major photoactive compounds.</p></caption><graphic xlink:href="molecules-25-04102-g004"/></fig><table-wrap id="molecules-25-04102-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04102-t002_Table 2</object-id><label>Table 2</label><caption><p>List of plant-based natural photoactive compounds with known photoactivity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Absorption Maxima</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Property and Groups</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Sources</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Possible Mode of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furanocoumarins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">333 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aromatic compounds possessing a furan ring.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Angelicae dahuricae, Tetradium daniellii, Glehnia littoralis, Heracleum persicum, Syzygium Sps, Ruta graveolens, Ficus sps.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DNA intercalation under dark<break/>type 2 PDT reaction.<break/>Crosslinking and adduct formation with DNA and RNA.<break/>Cell membrane damage.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-molecules-25-04102" ref-type="bibr">68</xref>,<xref rid="B69-molecules-25-04102" ref-type="bibr">69</xref>,<xref rid="B70-molecules-25-04102" ref-type="bibr">70</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyacetylenes and Thiophenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">488 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Furanoacetylenes thiarubrines, thiophenes, polyacetylene (aliphatic compounds with more than three conjugated triple bonds), thiophenes (aromatic acetylenes; e.g., phenylheptatriyne).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Asteraceae</italic> spp, <italic>Heliopsisa</italic>, <italic>Rudbeckia</italic> spp, <italic>Arnica, Centaurea scabiosa, Tagetes erecta</italic>, <italic>Porophyllum obscurum, Echinops</italic>, <italic>Bidens, Ambrosia chamissonis, T. minuta, E. latifolius</italic>, <italic>E. sgrijissi,</italic>
<italic>Rhaponticum uniflorum.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Membrane damage or erythrocyte leakage;<break/>type 1 and type 2 PDT reaction, as well as type 1 and 2 PDT mixed reaction.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-molecules-25-04102" ref-type="bibr">71</xref>,<xref rid="B72-molecules-25-04102" ref-type="bibr">72</xref>,<xref rid="B73-molecules-25-04102" ref-type="bibr">73</xref>,<xref rid="B74-molecules-25-04102" ref-type="bibr">74</xref>,<xref rid="B75-molecules-25-04102" ref-type="bibr">75</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">420&#x02013;480 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dicinnamoylmethane, curcumin, curcuminoids, demethoxycurcumin, bisdemethoxycurcumin.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Curcuma longa.</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell membrane is the primary target of curcuminoids.<break/>Induction of caspase-mediated cell death.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-molecules-25-04102" ref-type="bibr">76</xref>,<xref rid="B77-molecules-25-04102" ref-type="bibr">77</xref>,<xref rid="B78-molecules-25-04102" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alkaloids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">360 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chinolin alkaloids, pterins, benzylisoquinolines, beta-carbolines, harmine.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Guatteria blepharophylla</italic>, <italic>Berberis vulgaris, Sanguinaria Canadensis</italic>, <italic>Mahonia aquifolium</italic><break/><italic>Peganum harmala</italic>, <italic>Indigofera tinctoria.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Photo-oxidises histidine and tryptophan, resulting in DNA crosslinking.<break/>Photooxidation, type 1 PDT mechanism and targets mitochondria.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-molecules-25-04102" ref-type="bibr">79</xref>,<xref rid="B80-molecules-25-04102" ref-type="bibr">80</xref>,<xref rid="B81-molecules-25-04102" ref-type="bibr">81</xref>,<xref rid="B82-molecules-25-04102" ref-type="bibr">82</xref>,<xref rid="B83-molecules-25-04102" ref-type="bibr">83</xref>,<xref rid="B84-molecules-25-04102" ref-type="bibr">84</xref>,<xref rid="B85-molecules-25-04102" ref-type="bibr">85</xref>,<xref rid="B86-molecules-25-04102" ref-type="bibr">86</xref>,<xref rid="B87-molecules-25-04102" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anthraquinones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">437 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroxyanthraquinones, rhein, physcion, emodin, rubiadin, damnacanthol, soranjidiol, alizarin, purpurin, rubiadin, aloe-emodin, 1,5-dihydroxy przewalsquinone B, ziganein, uredinorubellins, caeruleoramularin, hypericin, cercosporin, elsinochromes A-C pleichrome, hypocrellin.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Polygonum cuspidatum, Heterophyllaea pustulata, H. lycioides</italic><break/><italic>Aloe vera, Rheum palmatum</italic>, <italic>Rumex crispus</italic><break/><italic>Polyathia suberosa, Dactylopius coccus, Xanthoria parietina, Drechslera avenae,</italic><break/><italic>Ramularia collo-cygni.</italic><break/><italic>H. perforatum</italic>, <italic>Fagopyrum esculentum.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type 1 and 2 PDT action.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-molecules-25-04102" ref-type="bibr">88</xref>,<xref rid="B89-molecules-25-04102" ref-type="bibr">89</xref>,<xref rid="B90-molecules-25-04102" ref-type="bibr">90</xref>,<xref rid="B91-molecules-25-04102" ref-type="bibr">91</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>